jonathan robert carter - The University of Sydney

апрель 12, 2020

CURRICULUM VITAE

JONATHAN ROBERT CARTER

MBBS DipRACOG FACS FRANZCOG CGO MS MD

Professor Gynaecological Oncology, The University of Sydney

Head Lifehouse Gynaecologic Oncology Group

Certified Gynaecologic Oncologist

Medical Board of Australia Registration: MED0001057241

Office Address: Lifehouse Gynaecological Oncology Group

Chris O’Brien Lifehouse

119-143 Missenden Rd

Camperdown, NSW 2050

Phone: (02) 85140256

Fax: (02) 93831256

Email: jonathan.carter@lh.org.au

Degrees & Diplomas:

H.S.C.

M.B., B.S.

Dip. R.A.C.O.G.

Higher School Certificate

University New South Wales

Diplomate Royal Australian College Obstetricians and

Gynaecologists

M.R.A.C.O.G. Pt 1 Part 1 Membership Royal Australian College Obstetricians

M.R.C.O.G. Pt 1 and Gynaecologists

Part 1 Membership Royal College Obstetricians and

F.M.G.E.M.S.

Gynaecologists

Foreign Medical Graduate Examination in Medical Sciences

M.R.A.C.O.G.

F.R.A.C.O.G.

F.L.E.X.

M.S.

F.A.C.A.

C.G.O.

F.A.C.S.

M.D.

(USA)

Membership Royal Australian College Obstetricians and

Gynaecologists

Fellow Royal Australian College Obstetricians and

Gynaecologists

Federal Licencing Examination (USA)

Master Science, University Minnesota. Thesis: Transvaginal

Color Flow Doppler Assessment in Gynecologic Neoplasms

Fellow American College Angiology

Certification Gynaecological Oncology Royal Australian

College Obstetricians and Gynaecologists

Fellow American College Surgeons

Doctorate Medicine, University New South Wales: Thesis:

Transvaginal Colour Flow Doppler Assessment of

Gynaecologic Tumours

1975

1981

1983

1984

1984

1986

1988

1990

1993

1993

1993

1994

1997

1999

Jonathan Carter, M.D., Page 2

Appointments:

1. Intern. St. Vincent's Hospital. Sydney, Australia. Jan 1981 - Dec 1981

2. Resident Medical Officer. St. Vincent's Hospital. Sydney, Australia. Jan

1982 - Dec 1983

3. Senior R.M.O. King George V Hospital. Sydney, Australia. Jan 1984 - Dec

1984

4. Registrar Ob/Gyn. St. George Hospital. Sydney, Australia. Jan 1985 - Dec

1985

5. Registrar Ob/Gyn. King George V Hospital. Sydney, Australia. Jan 1986 -

Dec 1988

6. Senior & Gyn-Oncology Registrar. King George V Hospital. Sydney. Jan

89 - Dec 89

7. Surgical/ Colo-Rectal Registrar. Royal Prince Alfred Hospital. Sydney. Jan

90 - June 90

8. Fellow Gynecologic Oncology. University of Minnesota Hospital. July 1990

- June 1992

9. Instructor Obstetrics & Gynecology; Gynecologic Oncology. University of

Minnesota Hospital. July 1992 - June 1993

10. Assistant Professor Gynecologic Oncology. University of Minnesota

Hospital. July 1993 - December 1995

11. Visiting Staff Specialist Gynecologic Oncology Hennepin County Medical

Center. Minneapolis, Minnesota. July 1993 - December 1995

12. Visiting Staff Specialist Gynecologic Oncology Methodist Hospital.

Minneapolis, Minnesota. July 1993 - December 1995

13. Visiting Staff Specialist Gynecologic Oncology. Fairview Riverside

Hospital. Minneapolis, Minnesota. July 1993 - December 1995

14. Visiting Staff Specialist Gynecologic Oncology Fairview Southdale

Hospital. Edina, Minnesota. July 1993 - December 1995

15. Visiting Staff Specialist Gynecologic Oncology Abbott Northwestern

Hospital. Minneapolis, Minnesota. 1994 - December 1995

16. Staff Specialist, Gynaecologic Oncology. King George V & Royal Prince

Alfred Hospital. Jan 1996 - June 1998

17. Visiting Specialist Gynaecologic Oncology St. Vincent’s Private Hospital.

Darlinghurst, NSW. 1996 - 2002

18. Visiting Specialist Sydney Adventist Hospital. Wahroonga NSW. 1996 -

2001

19. Visiting Specialist. North Gosford Private Hospital. North Gosford NSW.

1996 - 2002

20. Visiting Medical Officer. Liverpool Hospital. Liverpool NSW. 1997 - 2002

21. Visiting Specialist. St. Luke's Hospital. Potts Point, NSW. 1997

– Present

22. Associate Professor, Department of Obstetrics and Gynaecology, The

University of Sydney. March 2000 - present

23. Head, Gynaecological Oncology Unit King George Vth & Royal Prince

Alfred Hospital. Sydney, Australia. January 1996

24. Senior Staff Specialist, Gynaecologic Oncology. King George V & Royal

Prince Alfred Hospitals. July 1998

25. Head Gynaecology Services, Central Sydney Area Health Service.

February 2003.

26. Examiner Gynaecologic Oncology RANZCOG. 2002-2011.

27. Chair Education Committee, Sydney Cancer Centre. January 2004.


28. Head Gynaecology. Royal Prince Alfred Hospital. 2005-2008

29. Professor Gynaecological Oncology The University of Sydney 2006

30. Carter J. Member, Medical Practitioners Panel of Assessors. Queensland

Government, Department of Health. Queensland Government Gazette

2006-2010.

31. Chairman RPAH Medical Board. June 2008-2012

32. Appointed External Assessor University of Malaya Oct 2008-April 2011

33. Chairman MSEC SLHD. 2011-12

34. Advisory Panel Australian Cervical Cancer Foundation 2012

35. Honorary Visiting Medical Practitioner, Gynae-Oncology. Royal Prince

Alfred Hospital. 14 th November 2013

36. Carter J.

Staff Specialist Lifehouse at RPA. 18 th November 2013

37. Carter J.

Scientific Advisory Panel The Australian Gynaecological Cancer

Foundation. 24 th February 2014.

38. Carter J.

Scientific Advisor Panel. Compass Trial. A randomized controlled trial of primary HPV DNA testing for cervical screening in

Australia. March 2014

39. Carter J.

Health Care Complaints

Commission’s expert advisers panel.

19 th March 2014


Publications

1. Carter JR. Gudgeon C. Vacuum extraction and forceps delivery in a district hospital. Australian & New Zealand Journal of Obstetrics &

Gynaecology 1987;27:117-119.

2. Carter JR. Atkinson K, Coppleson M, Elliott P, Murray J, Solomon J,

Dalrymple C, Tattersall M, Duval P, Russell P, Bannatyne P. A comparative study of proliferating and invasive epithelial ovarian tumours in young women. Australian & New Zealand Journal of Obstetrics &

Gynaecology 1989;29(3(1)):245-249.

3. Carter JR. Child A. Serum uric acid levels in normal pregnancy. Australian

& New Zealand Journal of Obstetrics & Gynaecology 1989;29(3 Pt 2):313-

4.

4. Carter JR. Peat B, Dalrymple C, Atkinson K. Cervical tuberculosis--case report. Australian & New Zealand Journal of Obstetrics & Gynaecology

1989;29(3 Pt 1):270-2.

5. Dalrymple JC, Bannatyne P, Russell P, Solomon HJ, Tattersall MH,

Atkinson K, Carter JR. Duval P, Elliott P, Friedlander M, et al.

Extraovarian peritoneal serous papillary carcinoma. A clinicopathologic study of 31 cases. Cancer 1989;64(1):110-5.

6. Carter JR. Elliott P. Syringoma--an unusual cause of pruritus vulvae.

Australian & New Zealand Journal of Obstetrics & Gynaecology

1990;30(4):382-3.

7. Carter JR. Liver function in normal pregnancy. Australian & New Zealand

Journal of Obstetrics & Gynaecology 1990;30(4):296-302.

8. Carter JR. Unusual presentations of genital tract tuberculosis.

International Journal of Gynaecology & Obstetrics 1990;33(2):171-6.

9. Carter JR. Carson LF, Byers L, Moradi MM, Elg SA, Adcock LL, Prem KA,

Twiggs LB. Transvaginal ultrasound in gynecologic oncology. Obstetrical

& Gynecological Survey 1991;46(10):687-96.

10. Carter JR. Moradi MM, Elg S, Byers L, Adcock LA, Carson LF, Prem KA,

Twiggs LB. Pseudomyxoma peritonei--experience from a tertiary referral centre. Australian & New Zealand Journal of Obstetrics & Gynaecology

1991;31(2):177-8.

11. Carter JR. Serum bile acids in normal pregnancy. British Journal of

Obstetrics & Gynaecology 1991;98(6):540-3.

12. Carter JR. Uric acid in pregnancy and preeclampsia: an alternative hypothesis.[comment]. Australian & New Zealand Journal of Obstetrics &

Gynaecology 1991;31(1):91-2.

13. Carter JR. Ramirez C, Waugh R, Atkinson K, Coppleson M, Elliott P,

Murray J, Solomon J, Dalrymple C, Tattersall M, et al. Percutaneous urinary diversion in gynecologic oncology. Gynecologic Oncology

1991;40(3):248-52.

14. Carter JR. Early detection of ovarian cancer by transvaginal ultrasound.

Clin Devel Women's Cancer 1991;5(1):1-4.

15. Carter JR. Carson L, Twiggs L. An update on gestational trophoblastic disease. Postgraduate Obstet Gynecol 1991;11(8):1-8.

16. Carter JR. Moradi M, Adcock L, Carson L, Prem K, Twiggs L.

Pseudomyxoma peritonei: a local disease causing systemic effects. A review and treatment recommendations. Int J Gynecol Cancer

1991;1:243-247.


17. Carter JR. Letter to the editor. Australian & New Zealand Journal of

Obstetrics & Gynaecology 1991;31:91.

18. Carter JR. Elliott P, Russell P. Bilateral fibroepithelial polypi of labium minus with atypical stromal cells. Pathology 1992;24(1):37-9.

19. Carter JR. Carson LF, Elg S, Moradi M, Byers L, Adcock L, Prem K,

Twiggs LB. Transvaginal sonography as an aid in the clinical staging of carcinoma of the cervix. Journal of Clinical Ultrasound 1992;20(4):283-7.

20. Carlson JW, Soisson AP, Fowler JM, Carter JR. Twiggs LB, Carson LF.

Rectus abdominis myocutaneous flap for primary vaginal reconstruction.

Gynecologic Oncology 1993;51(3):323-9.

21. Carter JR. Carlson J, Hartenbach E, Saltzman A, Fowler J, Carson L,

Twiggs LB. Persistent postmolar gestational trophoblastic disease: use of transvaginal sonography and colour flow Doppler. Australian & New

Zealand Journal of Obstetrics & Gynaecology 1993;33(4):417-9.

22. Carter JR. Fowler J, Carlson J, Saltzman A, Byers L, Carson L, Twiggs

LB. Transvaginal color flow Doppler sonography in the assessment of gestational trophoblastic disease. Journal of Ultrasound in Medicine

1993;12(10):595-9.

23. Carter JR. Perrone T, Carson LF, Carlson J, Twiggs LB. Uterine malignancy predicted by transvaginal sonography and color flow Doppler ultrasonography. Journal of Clinical Ultrasound 1993;21(6):405-8.

24. Carter JR. Fowler J, Carlson J, Carson L, Twiggs LB. Borderline and invasive epithelial ovarian tumors in young women. Obstetrics &

Gynecology 1993;82(5):752-6.

25. Carter JR. Ruhr DM, Okagaki T, Fowler JM. Uterine lipoleiomyoma: a rare tumor. Journal of Ultrasound in Medicine 1993;12(8):491-2.

26. Carter JR. Fowler J, Carlson J, Carson L, Twiggs L. Prediction of malignancy using transvaginal color flow Doppler in patients with gynecologic tumors. Int J Gynecol Cancer 1993;3:279-284.

27. Carter JR. Carlson J, Fowler J, Carson L, Twiggs L. Complications of laparoscopic surgery. Gynaecological Endoscopy 1993;2:175-180.

28. Carter JR. Fowler J, Carlson J, Carson L, Twiggs L. Ovarian cancer in young women. Obstet Gynecol 1993;82:752-756.

29. Carter JR. Carlson J, Fowler J, Hartenbach E, Adcock L, Carson L,

Twiggs L. Invasive vulvar tumors in young women: A disease of the immunosuppressed? Gynecol Oncol 1993;51:307-310.

30. Fowler JM, Carter JR. Carlson JW, Maslonkowski R, Byers LJ, Carson

LF, Twiggs LB. Lymph node yield from laparoscopic lymphadenectomy in cervical cancer: a comparative study. Gynecologic Oncology

1993;51(2):187-92.

31. Carlson JW, Fowler JM, Saltzman AK, Carter JR. Chen MD, Mitchell SK,

Dunn D, Carson LF, Adcock LL, Twiggs LB. Chemoprophylaxis with oral ciprofloxacin in ovarian cancer patients receiving taxol. Gynecologic

Oncology 1994;55(3 Pt 1):415-20.

32. Carter JR. An update on ovarian cancer screening. Australian & New

Zealand Journal of Obstetrics & Gynaecology 1994;34(2):169-74.

33. Carter JR. Fowler J, Carson L, Carlson J, Twiggs LB. How accurate is the pelvic examination as compared to transvaginal sonography? A prospective, comparative study. Journal of Reproductive Medicine

1994;39(1):32-4.


34. Carter JR. Saltzman A, Hartenbach E, Fowler J, Carson L, Twiggs LB.

Flow characteristics in benign and malignant gynecologic tumors using transvaginal color flow Doppler. Obstetrics & Gynecology 1994;83(1):125-

30.

35. Carter JR. Lau M, Saltzman AK, Hartenbach EM, Chen MD, Johnson PR,

Fowler JM, Carlson JW, Carson LF, Twiggs LB. Gray scale and color flow

Doppler characterization of uterine tumors. Journal of Ultrasound in

Medicine 1994;13(11):835-40.

36. Carter JR. Screening for women for ovarian cancer with no family history of ovarian cancer. Int J Corr Soc Obstet Gynecol 1994;35(3):1-8.

37. Carter JR. Is Topotecan the new Taxol in ovarian cancer? Clin Devel

Women's Cancer 1994;7(2):1-4.

38. Carter JR. The utilization of transvaginal color flow Doppler in the assessment and management of gynecologic tumors. Cope

1994;10(5):26-28.

39. Carter JR. Oakley G, Carlson J, Fowler J, Adcock L, Carson L, Twiggs L.

A prospective non randomized study of alternating courses of cisplatin/cytoxan and carboplatin/etoposide in advanced ovarian cancer. It

J Ob Gyn 1994;1:10-15.

40. Carter JR. Letter to the editor. Australian & New Zealand Journal of

Obstetrics & Gynaecology 1994.

41. Elg S, Carson L, Brooker D, Carter JR. Twiggs L. Infectious morbidity after radical vulvectomy. Infectious Diseases in Ob Gyn 1994;2:130-135.

42. Fowler JM, Hartenbach EM, Reynolds HT, Borner J, Carter JR. Carlson

JW, Twiggs LB, Carson LF. Pelvic adhesion formation after pelvic lymphadenectomy: comparison between transperitoneal laparoscopy and extraperitoneal laparotomy in a porcine model. Gynecologic Oncology

1994;55(1):25-8.

43. Byers LJ, Osborne JL, Carson LF, Carter JR. Haney AF, Weinberg JB,

Ramakrishnan S. Increased levels of laminin in ascitic fluid of patients with ovarian cancer. Cancer Letters 1995;88(1):67-72.

44. Carlson JW, Saltzman AK, Carter JR. Hartenbach EM, Johnson PR,

Chen MD, Carson LF, Twiggs LB. Recurrent squamous cell carcinoma in a rectus abdominis neovagina. Gynecologic Oncology 1995;59(1):159-61.

45. Carlson JW, Nazarian GK, Hartenbach E, Carter JR. Dusenbery KE,

Fowler JM, Hunter DW, Adcock LL, Twiggs LB, Carson LF. Management of pelvic venous stenosis with intravascular stainless steel stents.


46. Carter JR. Saltzman A, Chen D, Carney P, Johnson P, Hartenbach E,

Fowler J, Carson L, Twiggs L. Quality of life assessment in gynaecological cancer patients. Australian & New Zealand Journal of Obstetrics &

Gynaecology 1995;35(3):293-7.

47. Carter JR. Lau M, Fowler JM, Carlson JW, Carson LF, Twiggs LB. Blood flow characteristics of ovarian tumors: implications for ovarian cancer screening. American Journal of Obstetrics & Gynecology

1995;172(3):901-7.

48. Carter JR. Lau M, Twiggs L. A comparison of pulsatility and resistive indices in gynecological tumor detection using transvaginal ultrasound.

Vascular Surgery 1995;29(1):29-35.

49. Carter JR. Lau M. Transvaginal sonography in gynecologic oncology. The

Female Patient 1995;20(4):79-88.


50. Carter JR. Long term treatment of a young woman with stage IB or IC ovarian papillary serous carcinoma: surgery, adjuvant therapy or surveillance? Int J Corr Soc Obstet Gynecol 1995;36(11):5-7.

51. Fowler J, Carter JR. Laparoscopic management of the adnexal mass in postmenopausal women. J Gyn Tech 1995;1(1):7-10.

52. Hartenbach EM, Saltzman AK, Carter JR. Fowler JM, Hunter DW,

Carlson JW, Twiggs LB, Carson LF. Nonsurgical management strategies for the functional complications of ileocolonic continent urinary reservoirs.


53. Hartenbach EM, Saltzman AK, Carter JR. Twiggs LB. A novel strategy using G-CSF to support EMA/CO for high-risk gestational trophoblastic disease. Gynecologic Oncology 1995;56(1):105-8.

54. Saltzman AK, Carter JR. Fowler JM, Carlson JW, Hartenbach EM, Julian

SE, Carson LF, Twiggs LB. The utility of preoperative screening colonoscopy in gynecologic oncology. Gynecologic Oncology

1995;56(2):181-6.

55. Carlson JW, McGlennen RC, Gomez R, Longbella C, Carter JR. Carson

LF. Sebaceous carcinoma of the vulva: a case report and review of the literature. Gynecologic Oncology 1996;60(3):489-91.

56. Carlson JW, Carter JR. Saltzman AK, Carson LF, Fowler JM, Twiggs LB.

Gynecologic reconstruction with a rectus abdominis myocutaneous flap: an update. Gynecologic Oncology 1996;61(3):364-8.

57. Carter JR. An update on the evaluation of the abnormal Pap smear.


1996;Supp 9(3):3-5.

58. Carter JR. The assessment and management of postmenopausal bleeding. Australian & New Zealand Journal of Obstetrics & Gynaecology

1996;Supp 36(4):3-5.

59. Twiggs L, Carter JR. Fowler J, Carson L, Herrick W, Kile R, Potish R. An estimation of the resource utilization with the introduction of laparoscopic pelvic lymphadenectomy prior to radical hysterectomy in early cervical carcinoma: a propress report from the laparoscopic study group at the

Women's Cancer Center at the University of Minnesota Health Science

Center. Int J Gynecol Cancer 1996;6:267-272.

60. Carter JR. Chen MD, Fowler JM, Carson LF, Twiggs LB. The effect of prolonged cycles of chemotherapy on quality of life in gynaecologic cancer patients. Journal of Obstetrics & Gynaecology Research 1997;23(2):197-

203.

61. Carter JR. Ovarian cancer early detection: facts surrounding the myths.


1997;Supp 37(1):9-11.

62. Carter JR. Johnson P, Saltzman A, Chen D, Carney P, Hartenbach E,

Fowler J, Carson L, Twiggs L. Lack of adverse effect on quality of life of up to 6 cycles of chemotherapy in gynecologic cancer patients. Int J

Gynecol Cancer 1997;7(439-444).

63. Cosin JA, Carter JR. Paley P, Chen MD, Johnson P, Fowler JM, Twiggs

LB, Carson LF. A simplified method for detubularization in the construction of a continent ileocolic reservoir (Miami pouch). Gynecologic Oncology

1997;64(3):436-41.


64. MacLeod C, Fowler A, Dalrymple C, Atkinson K, Elliott P, Carter JR. Highdose-rate brachytherapy in the management of high-grade intraepithelial neoplasia of the vagina. Gynecologic Oncology 1997;65(1):74-7.

65. MacLeod C, Fowler A, Dalrymple C, D'Costa I, Firth I, Atkinson K, Elliott P,

Carter JR. High dose rate brachytherapy in the management of carcinoma of the cervix: an 8-year Australian experience. Australian &

New Zealand Journal of Obstetrics & Gynaecology 1997;37(3):342-347.

66. MacLeod C, Fowler A, Duval P, D'Costa I, Dalrymple C, Firth I, Elliott P,

Atkinson K, Carter JR. High-dose-rate brachytherapy alone posthysterectomy for endometrial cancer. International Journal of Radiation

Oncology, Biology, Physics 1998;42(5):1033-9.

67. Parker J, Hayes C, Wong F, Carter JR. Laparoscopic ilioinguinal nerve injury. Gynaecological Endoscopy 1998;7:327-329.

68. Carter JR. MacLeod C, Fowler A, Chan F, Dalrymple C, Wong F.

Argument for the surgical staging of apparent early endometrial cancer.


1999;39(4):438-42.

69. Carter JR. Cervical tumor characterization by transvaginal color flow

Doppler ultrasound. Int J Gynecol Cancer 1999;9:279-284.

70. Carter JR. Early screening for ovarian cancer. Int J Corr Soc Obstet

Gynecol 1999;40(11):5-7.

71. MacGibbon A, Bucci J, MacLeod C, Solomon J, Dalrymple C, Firth I,

Carter JR. Whole abdominal radiotherapy following second-look laparotomy for ovarian carcinoma. Gynecologic Oncology 1999;75(1):62-

7.

72. MacLeod C, Fowler A, Duval P, D'Costa I, Dalrymple C, Elliott P, Atkinson

K, Firth I, Carter JR. Adjuvant high dose rate brachytherapy with or without external beam radiotherapy posthysterectomy for endometrial cancer. Int J Gynecol Cancer 1999;9:247-255.

73. Nada W, Parker J, Carter JR. Choriocarcinoma developing after prolonged molar surveillance. Australian & New Zealand Journal of

Obstetrics & Gynaecology 1999;39(4):490-2.

74. Saltzman AK, Hartenbach EM, Carter JR. Contreras DN, Twiggs LB,

Carson LF, Ramakrishnan S. Transforming growth factor-alpha levels in the serum and ascites of patients with advanced epithelial ovarian cancer.

Gynecologic & Obstetric Investigation 1999;47(3):200-4.

75. Carter JR. An experience with transvaginal sonography in gynaecologic tumour surveillance. Australian & New Zealand Journal of Obstetrics &

Gynaecology 2000;40(4):438-41.

76. Carter JR. Re: Home within 24 hours of laparoscopic hysterectomy.[comment]. Australian & New Zealand Journal of Obstetrics

& Gynaecology 2000;40(1):108.

77. Elliott P, Coppleson M, Russell P, Liouros P, Carter JR. MacLeod C,

Jones M. Early invasive (FIGO Stage IA) carcinoma of the cervix: a clinico-pathologic study of 476 cases. Int J Gynecol Cancer

2000;10(3):42-52.

78. McLeod C, Beale P, Tattersall M, Dalrymple C, Atkinson K, Carter JR.

Early results of chemo-radiotherapy for the definitive treatment of cervix cancer. Australian & New Zealand Journal of Obstetrics & Gynaecology

2000;40(3):341-2.


79. Scolyer R, Carter JR. Russell P. Aggressive endometriosis. Report of a case. Int J Gynecol Cancer 2000;10(3):257-262.

80. Vinod SK, MacLeod CA, Dalrymple C, Elliott P, Atkinson K, Carter JR.

Firth I. Surgery and post-operative radiotherapy for early stage cervical cancer. Australian & New Zealand Journal of Obstetrics & Gynaecology

2000;40(1):66-9.

81. Carter JR. Valmadre S, Dalrymple C, Atkinson K, Young C. Management of large bowel obstruction in advanced ovarian cancer with intraluminal stents. Gynecologic Oncology 2002;84(1):176-9.

82. Inthasorn P, Carter JR. Valmadre S, Beale P, Russell P, Dalrymple C.

Analysis of clinicopathologic factors in malignant mixed Mullerian tumors of the uterine corpus. Int J Gynecol Cancer 2002;12(4):348-53.

83. Valmadre S, Atkinson K, Houghton R, Carter JR. McKenzie P, Russell P,

Dalrymple C. High grade abnormalities following an 'inconclusive' smear.


2002;42(4):391-4.

84. Varol N, Maher P, Vancaillie T, Cooper M, Carter JR. Kwok A, Pesce A,

Reid G. A literature review and update on the prevention and management of fluid overload in endometrial resection and hysteroscopic surgery. Gynaecological Endoscopy 2002;11:19-26.

85. Carter JR. Why is the rest of the world moving to liquid based cytology and human papilloma virus (HPV) triage? Aust J Gen Practice

2003;3(5):4-5.

86. Carter JR. Letter to the editor. Medical Observer 2003.

87. Inthasorn P, Beale P, Dalrymple C, Carter JR. Malignant mixed mullerian tumour of the ovary: prognostic factor and response of adjuvant platinumbased chemotherapy. Australian & New Zealand Journal of Obstetrics &

Gynaecology 2003;43(1):61-4.

88. Joshua AM, Carter JR. Beale P. The use of taxanes in choriocarcinoma; a case report and review of the literature. Gynecologic Oncology

2004;94(2):581-3.

89. Liu J, Rose B, Huang X, Liao G, Carter JR. Wu X, Thompson C.

Comparative analysis of characteristics of women with cervical cancer in high- versus low-incidence regions. Gynecologic Oncology

2004;94(3):803-10.

90. Rao A, Land R, Carter JR. Management of upper gastrointestinal obstruction in advanced ovarian cancer with intraluminal stents. Gynecol

Oncol 2004:;95(3): 739-741

91. Wei L, Thompson CH, Cossart YE, O’Brien CJ, Liu J, Scolyer RA, Carter

JR, Dalrymple C, Rose B. The site of infection and ethnicity of the patient influence the biological pathways to HPV-induced mucosal cancer.

Modern Pathology 2003 2004;17(9):1031-1037

92. Santos LD, Carter JR. Killingsworth M. Polypoid endometrioma of the rectal serosa and retroperitoneal endometriosis in a 70-year-old woman.

Pathology 2004;36(1):91-4.

93. Land R, Carter JR, Houghton R, Atkinson K, Dalrymple C. Gynaecology meets neurology: Paraneoplastic cerebellar degeneration. Aust NZ J

Obstet Gynaecol 2005;45(1):79.

94. Paramasivam S, Tripcony L, Crandon A, Quinn M, Hammond I, Marsden

D, Proietto A, Davy M, Carter JR , Nicklin J, Perrin L, Obermair A.

Prognostic importance of preoperative CA125 in FIGO stage I epithelial

Jonathan Carter, M.D., Page 10 ovarian cancer: an Australian Multicenter Study. JCO 2005;23(25):5938-

5942.

95. Dray M, Russell P, Dalrymple C, Wallman N, Angus G, Leong A, Carter

JR, Cheerala B. p16 INK4a as a complementary marker of high-grade intraepithelial lesions of the uterine cervix. I: Experience with squamous lesions in 189 consecutive cervical biopsies. Pathology 2005; 37(2): 112-

124.

96. Pather S, Carter JR . The use of the laparoscopic Endoclose device to insert external retention sutures in a morbidly obese patient at laparotomy.

J Gyn Surgery 2005;21(3):125-127.

97. Carter JR , Pather S.An overview of uterine cancer and its management.

Expert Rev. Anticancer Ther 2006;6(1):33-41

98. Harrison J, Carter JR , Young J, Solomon M. Difficult clinical decisions in gynaecologic oncology: identifying priorities for future clinical research. Int

J Gynecol Cancer 2006;16:1-7.

99. Carter JR , Sim J, Land R, Dalrymple C, Abdel-Hadi M, Pather S.

Recurrence After Treatment for High Grade Dysplasia: Should We Modify

Our Post Treatment Surveillance Protocols? Aust NZ J Obstet Gynaecol

2006;46:360-362

100. Carter JR , Pather S, Abdel-Hadi M, Nattress K, Dalrymple C, Beale P.

Not all ovarian cysts in young woman are benign. A case series and review of the management of complex adnexal masses in young women.

Aust NZ J Obstet Gynaecol 2006; 46(4):350-355

101. Pather S, O'Leary M, Carter JR.

An overview of uterine cancer and its management. Womens Health. 2007 3(1).

102. Susman, M, Cooper, C, Cooper M, Carter, JR, Russell P. (2007).

"Gonadoblastoma progressing to dysgerminoma in a 55-year-old woman with normal karyotype." Pathology 2007; 39: 284.

103. Obermair A, Fuller A, Lopez-Varela E, van Gorp T, Vergote I, Eaton L,

Fowler J, Quinn M, Hammond I, Marsden D, Proietto A, Carter JR, Davy

M, Tripcony L, Abu-Rustum N. A new prognostic model for FIGO stage 1 epithelial ovarian cancer. Gynecologic Oncology 2007;104:607-11.

104. Pather S, Atkinson K, Wang I, Russell P, Kesby G, Carter JR . Virilization in pregnancy due to a borderline mucinous ovarian tumor. Journal of

Obstetrics and Gynaecology Research. 2007;33(3):384-7.

105. Dalrymple C, Valmadre S, Cook A, Atkinson K, Carter JR , Houghton

CRS, Russell P. Cold knife versus laser cone biopsy for adenocarcinoma in situ of the cervix-a comparison of management and outcome.

International Journal of Gynecological Cancer 2008; 18: 116-120

106. Stanwell P, Russell P, Carter J , Pather S, Heintze S, Mountford C.

Evaluation of ovarian tumors by proton magnetic resonance spectroscopy at three Tesla. Investigative radiology. 2008 Oct;43(10):745-51.

107. Al-Rayyan ES, Duqoum WJ, Sawalha, MS, Nascimento MC, Pather S,

Dalrymple JC, Carter JR . Secondary malignancies in ovarian dermoid cyst. Saudi Med J 2009; 30(4):179-183

108. Fulham MJ, Carter J , Baldey A, Hicks RJ, Ramshaw JE, Gibson M. The impact of PET-CT in suspected recurrent ovarian cancer: A prospective multi-centre study as part of the Australian PET Data Collection Project.

Gynecologic Oncology. 2009;112(3):462-8.


109. Rao A, Pather S, Dalrymple C, Mackie A, Deans R, Carter JR . The role of

HPV testing in patients with possible high-grade cytology. J Obstet

Gynecol Research 2009, 35(3):503-506

110. Fulham MJ, Carter J , Hicks RJ. The impact of PET-CT in suspected recurrent ovarian cancer: A prospective multi-centre study as part of the

Australian PET Data Collection Project. Gynecologic Oncology. Letter.

Gynecol Oncol 2009; 114(3):536-537

111. Harrison JD, Juraskova I, Anderson C, Nattress K, Beale P, Lopez A,

Carter J . Cancer Antigen 125 Level and the Type and Timing of

Treatment for Recurrent Ovarian Cancer A Clinical Dilemma, But What

Would Women Do? Int J Gynecol Cancer 2009;19: 1037-1046

112. Chunping J, Pather S, Dalrymple C, Al-Rayyan E, Nascimento M, Beale P,

Jackson M, Milross C, Carter J . Experience with Uterine

Leiomyosarcoma: A study of 22 cases. International Medicine and Health

Guidance News. August 2009, Vol.15 No.17: 24-28

113. Welsh AW, Ellwood D, Carter J , Peduto AJ, Vedelago J, Bennett M.

Opinion: Integration of diagnostic and management perspectives for placenta accreta. ANZJ Obstet Gynaecol 2009;49:578-587

114. Gainford MC, Tinker A, Carter J , Petru E, Nicklin J, Quinn M, Hammond I,

Elit L, Lenhard M, Friedlander M. Malignant Transformation within Ovarian

Dermoid Cysts. An Audit of Treatment Received and Patient Outcomes.

An Australia New Zealand Gynaecological Oncology Group

(ANZGOG)and Gynaecologic Cancer Intergroup (GCIG) Study". Int J Gyn

Cancer 2010;20:75-81

115. Carter J , Szabo R, Sim, W, Pather S, Dalrymple C, Philp S, Patel P,

Nattress K, Cotterell S. Fast track surgery: a clinical Audit. Aust NZJ

Obstet Gynecol 2010; 50:159-163

116. Arora V, Nattress K, Philp S, Pather S, Dalrymple C, Atkinson A, Smirnova

S, Cotterell S, Carter J . Patient Satisfaction with In-patient Care Provided by the Sydney Gynaecological Oncology Group. Patient Related Outcome

Measures. 2010;1:179-184

117. Carter, J . Laparoscopy or laparotomy for early endometrial cancer?. The

Lancet Oncology.

2010. p. 1021-1022

118. Carter J , Philp S, Arora V. Fast track gynaecologic surgery in the overweight and obese patient. Int J Clinical Med 2010;1(2):64-69

119. Pather S, Tai D, Philp S, Nattress K, Carter J , Dalrymple C, Atkinson K. A prospective study assessing patient satisfaction at a large tertiary gynecologic oncology/dysplasia unit. Patient Related Outcome Measures.

2010; 1:149-152.

120. Carter J , Ding Z, Rose B. HPV and cervical disease: a review. Aust NZJ

Obstet Gynaecol 2011; 51:103-108

121. Carter J , Philp S, Arora V. Early Discharge after Major Gynaecological

Surgery: Advantages of Fast Track Surgery.

OJOG

2011; 1:1-5

122. Ding Z, Jiang C, Shore T, Pather S, Dalrymple C, Atkinson K, Murali R, Al-

Rayyan E, Luo K, Carter J . The outcome of cervical intraepithelial neoplasia 2 diagnosed by punch biopsy in 131 women. J Obstet Gynaecol

Res 2011; 37(7):754-761

123. Rao A, Carter J . Ultrasound screening and ovarian cancer: is there a future? J Minim Invasive Gynecol 2011;18(1):24-30


124. Lim C, Leecy T, McKenzie P, Pather S, Carter J . Russell P. Two cases of adenosquamous carcinoma of the cervix with extensive in situ and invasive endometrial extension. Int J Gynecol Path 2011 30(2):193-197

125. Anderson C, Carter J , Nattress K, Beale P, Philp S, Harrison J, Juraskova

I. “The booklet helped me not to panic”: A pilot of a decision aid for asymptomatic women with ovarian cancer and with rising CA-125 levels.

International Journal of Gynecological Cancer. 2011; 21(4):737-743

126. Carter J , Smirnova S. A personal experience with radical abdominal trachelectomy for the conservative management of invasive cervical cancer. Aust NZ J Obstet Gynaecol 2011;51:177-183

127. Carter J , Philp S. Assessing outcomes after fast track surgical management of corpus cancer. OJOG 2011;1:139-143

128. Carter J . Letter to the Editor. Recognition and management of laparoscopic complications. O&G Magazine 2011; 13(3):80

129. Carter J . Laparoscopy or Laparotomy for Endometrial Cancer. A review of three prospective randomized trials. Aust NZJ Obstet Gynaecol

2011;51:387-392

130. Pather S, Loadsman JA, Mansfield C, Rao A, Arora V, Philp S, Carter J .

Perioperative outcomes after total laparoscopic hysterectomy compared with fast-track open hysterectomy: a retrospective case-control study. Aust

NZ J Obstet Gynaecol 2011;51:393-396

131. Carter J , Philip S. Development and extended experience with a fast track surgery program in a gynaecological oncology service. Open Women’s

Health Journal 2011;5:7-10

132. Pather S, Won H, Carter J . A borderline serous tumour of the broad ligament complicating pregnancy. A brief report : J. Obstet Gynaecol

2011;31:350-351.

133. Pather S, Loadsman JA, Gopalan PD, Rao A, Philp S, Carter J . The role of transversus abdominus plane blocks in women undergoing total laparoscopic hysterectomy: a retrospective review. Aust NZ J Obstet

Gynaecol 2011;51:544-547

134. Tang A, Kondalsamy-Chennakesavan S, Ngan H, Zusterzeel P, Quinn M,

Carter J , Leung Y, Obermair A. Prognostic value of preoperative serum

CA125 in ovarian tumors of low malignant potential: a multicenter collaborative study. Gynecol Oncol 2012;126:36-40.

135. Carter J.

Letter to Editor. ANZJ Obstet Gynaecol 2012; 52:496-497

136. Bonner C, Nattress K, Anderson C, Carter J, Milross C, Philp S,

Juraskova I. Chore or priority? Barriers and facilitators affecting dilator use after pelvic radiotherapy for gynaecological cancer. Supportive Care in

Cancer 2012; 20(10):2305-2313

137. Carter J . Fast track surgery in gynaecology and gyneacologic oncology. A review of a rolling clinical audit. ISRN Surgery, vol. 2012, Article ID

368014, 19 pages, 2012. doi:10.5402/2012/368014.

138. Carter J . Letter to Editor, Gynecol Oncol 2013; 128:147-152

139. Obermair A, Tang A, Kondalsamy-Chennakesavan, S, Ngan H, Zusterzeel

P, Quinn M, Carter J , Leung Y, Janda M. Nomogram to predict the probability of relapse in patients diagnosed with borderline ovarian tumors.

Int J Gynecol Cancer 2013;23:264-267

140. Carter J . A contemporary review of uterine cancer management.

ANZJOG 2013; 53(6):517-524


141. Carter J . Letter to Editor. Obstet Gynecol. Enhanced recovery in gynecologic surgery. Obstet Gynecol 2013; 122(6):1305

142. Carter J, Philp S, O’Connell R. A 5-Year review of gynaecological oncology patients managed by a fast track surgery program. IJCM 2014;

5: 36-41

Submitted

1. Playdon MC, Nagle, CM, Ibiebele TI, Protani MM, Carter J , Hyde SE,

Neesham D, Nicklin JL, Ferrucci LM, Mayne ST, Webb PM for the

Australian Ovarian Cancer Study Group. Diet and survival after a diagnosis of ovarian cancer. Submitted 2014

Books

1. Carter JR. An Atlas of Transvaginal Ultrasound. 1st ed. Philadelphia: JB

Lippincott Company; 1994 ISBN 0-397-51460-3.

2. Carter JR. Ecografia Transvaginale. Atlante per il ginecologo. Roma:

Antonio Delfino Editore medicina-scienze.; 1996 ISBN 88-72-87-102-6.

3. Carter JR. Clinical Practice and Management Policies. The Sydney

Gynaecologic Oncology Group. Sydney: Sydney Cancer Centre; 2004

ISBN 0-646-44209-0.

Book Chapters

1. Carter JR. The vacuum extractor. In: Studd J, editor. Progress in

Obstetrics and Gynaecology: Churchill Livingstone Press; 1990. p. 137-

154.

2. Carter JR. Carson L, Twiggs L. Gynecologic Oncology. In: David Nyberg

LH, Marcela Bohm-Velez and Ellen Mendelson, editor. Transvaginal

Ultrasound: Mosby Year Book Publishers; 1992. p. 241-265.

3. Carter JR. Twiggs L. The role of transvaginal sonography in gynaecologic oncology: Churchill Livingstone Press; 1993

4. Anderson J, Carter JR. Ultrasonography of Pathological Pregnancy

Conditions: Churchill Livingstone Publishers; 1999 0-443-05239-5.

5. Carter JR. Ultrasound Screening for Gynaecological Malignancy. London:

Churchill Livingstone Publishers; 1999 0-443-05239-5.

6. Carter JR. Ultrasonography of Malignant Neoplasms Metastatic to the

Female Genital Tract: Churchill Livingstone Publishers; 1999 0-443-

05239-5.

7. Carter JR. Gynaecological Cancers: Surgical Management. Amsterdam:

Harwood Academic/Gordon and Breach Science International Publishers;

1999 90-5702-470-5.

8. Carter JR. Surgery for Advanced Ovarian Cancer. Greer, B: Current

Medicine, Inc; 1999 0-8385-0316-0.

9. Carter JR. Elliott P. Changing trends in the epidemiology of cervical cancer: Oxford University Press; 2000 019-588545-7.

10. Carter JR. Primary Surgery for Ovarian Cancer in Gynecologic Cancer. In:

Gershenson G, McGuire, Quinn, Thomas, editor. Controversies in

Management: Elsevier Churchill Livingstone Publishers; 2004. p. 399-409.

11. Carter JR. Ovarian and Fallopian Tube Cancer: A GMTT Funded Project;

2004 ISBN 1-74080-0605.


12. Carter JR . Prognostic factors in advanced gynaecological cancer. In:

Glare P, Christakis N, eds. Prognosis in advanced cancer : Oxford

University Press 2008:187-99.

13. Carter JR.

Cervical Screening in Women’s Health an Evidence Base

Guide. Edited by Abbott J, Bowyer L, Finn M. Elsevier Australia. 2013

14. Carter JR.

Cervical Cancer in Women’s Health an Evidence Base Guide.

Edited by Abbott J, Bowyer L, Finn M. Elsevier Australia. 2013

International Presentations

1. Elg S, Brooker D, Carson L, Twiggs L, Adcock L, Carter JR. Dunn D.

Infectious morbidity of surgery with or without radiation in vulvar cancer patients. Poster presentation International Society for Study Vulva

Disease Meeting, Oxford England September 1991.

2. Moradi M, Elg S, Carter JR. Olson M, Adcock L, Prem K, Twiggs L,

Carson L, Ramakrishnan S. Levels of macrophage colony-stimulating factor (M-CSF), Interleukin-1 (IL-1), Interleukin-6 (IL-6) and TNF-alpha in human ovariann cancer. Poster presentation European and American

Association of Cancer Research, Italy November 1991.

3. Carter JR. Fowler J, Carlson J, Adcock L, Carson L, Twiggs L. Prediction of malignancy using transvaginal color flow Doppler. Oral presentation 5th

World Congress on Transvaginal Sonography, Orlando Florida May 1992.


Twiggs L. Vulvar cancer in young women: a disease of the immunosuppressed? Oral presenation 12th International Society Study

Vulva Disease Congress, Quebec Canada September 1993.

5. Carter JR. Fowler J, Carlson J, Carson L, Twiggs L. Transvaginal sonography of uterine tumors. Assessment of grey scale and color flow

Doppler results. Oral presentation 3rd World Congress of Ultrasound in

Obstetrics and Gynecology, Las Vegas Nevada, USA October 1993.

6. Carter JR. Fowler J, Carlson J, Saltzman A, Byers L, Hartenbach E,

Carson L, Twiggs L. Flow characteristics in benign and malignant gynecologic tumors using transvaginal color flow Doppler. Oral presentation III World Congress of Ultrasound in Obstetrics and

Gynecology Las Vegas, Nevada 25th-28th October 1993.

7. Carter JR. Fowler J, Carlson J, Carson L, Twiggs L. Prediction of malignancy using transvaginal color flow Doppler in patients with gynecologic tumors. Poster presentation The III World Congress of

Ultrasound in Obstetrics and Gynecology Las Vegas, Nevada 25th-28th

October 1993.

8. Carter JR. Fowler J, Carlson J, Saltzman A, Byers L, Carson L, Twiggs L.

Transvaginal color flow Doppler in the assessment of gestational trophoblastic disease. Poster presentation III World Congress of

Ultrasound in Obstetrics and Gynecology Las Vegas, Nevada 25th-28th

October 1993.

9. Fowler J, Carter JR. Carlson J, Maslonkowski R, Byers L, Carson L,

Twiggs L. Lymph node yield from laparoscopic lymphadenectomy in cervical cancer: a comparative study. Oral presentation 8th World

Congress of Cervical Pathology and Colposcopy, Chicago Illinois USA

May 1993.


10. Carter JR. Ultrasound assessment of uterine cancer. Oral presentation

11th World Congress on Ultrasound in Obstetrics and Gynecology.

Melbourne Australia 23rd-28th October 2001.

11. Carter JR. Experience with transvaginal ultrasound in gynecologic tumour surveillance. Oral presentation 11th World Congress on Ultrasound in

Obstetrics and Gynecology. Melbourne Australia 23rd October-28th

October 2001.

12. Carter JR. Laparoscopy in gynaecologic oncology, we can but should we.

Invited speaker 1st Guangzhou International Symposium on Oncology.

Guangzhou China 28th-30th April 2002.

13. Carter JR. How to follow up treated patients. Invited Speaker Meet the

Professor Session 9th Biennial Meeting of the International Gynecologic

Cancer Society. Seoul, Korea 20th-24th October 2002.

14. Inthasorn P, Beale P, Dalrymple C, Carter JR. Malignant mixed Mullerian tumor of the ovary: prognostic factor and response of adjuvant platinumbased chemotherapy. Poster presentation 9th Biennial Meeting of the

International Gynecologic Cancer Society. Seoul, Korea 20th-24th

October 2002.

15. Liu J, Thompson C, Huang X, Liao G, Rose B, Carter JR. The differences of human papillomavirus prevalence and clinicopathological features in cervical cancer between Chinese and Australian Women. Poster presentation 9th Biennial Meeting of the International Gynecologic Cancer

Society. Seoul, Korea 20th-24th October 2002.

16. Carter JR. FIGO staging of gynaecological malignancy. Oral presentation

International Academy of Pathology Meeting, Darling Harbour, Sydney,

Australia 30th March-1st June 2003.

17. Beale P, Carter JR. Dalrymple C, Fazekas B, Zhou C, Childs A, Nattress

K. A pilot study of dendritic cell immunotherapy in women with epithelial ovarian or primary peritoneal cancer. Poster presentation at the 10th

Biennial Meeting of the International Gynecologic Cancer Society.

Edinburgh Scotland October 2004.

18. Liu J, Rose B, Dalrymple C, Carter JR. Qian D, Huang X, Tattersall M,

Thompson C. Cervical intraepithelial neoplasia and invasive cervical cancer in relation to human papillomavirus and cofactors: a case conrol study in China and Australia. The 10th Biennial Meeting of the

International Gynecologic Cancer Society. Edinburgh Scotland 3rd-7th

October 2004.

19. Obermair A, Paramasivam S, Quinn M, Marsden D, Hammond I, Proietto

A, Davy M, Carter JR. Perrin L, Nicklin J, Crandon A, Tripcony L.

Prognostic significance of preoperative CA125 in FIGO stage I epithelial ovarian cancer-an Australian multicentre study. The 10th Biennial Meeting of the International Gynecologic Cancer Society. Edinburgh Scotland 3rd-

7th October 2004.

20. Nattress K, Beale P, Carter J , Clark K, Dalrymple C, Waters A. The complex palliative care needs of women with epithelial ovarian cancer: a retrspective review. Poster presentation 11th Biennial Meeting

International Gynecologic Cancer Society Santa Monica, California, USA

October 14-18 2006.

21. Nattress K, Andrews L, Carter J, Culling B, Pather S, Hamilton A. An innovative multidisciplinary approac for the management of women at high risk of breast and ovarian cancer. Poster presentation 11th Biennial


Meeting International Gynecologic Cancer Society Santa Monica,

California, USA October 14-18 2006

22. Juraskova I, Harrison J, Nattress K, Anderson C, Lopez AL, Beale P,

Carter J . Rising CA125 in asymptomatic women: a clinical dilemma but what would women want to do? Accepted Abstract and poster 12 th

Biennial Meeting of the International Gynecologic Cancer Society Bangkok

Thailand 2008

23. Taylor J, Lobb E, Dalrymple C, Carter J, Juraskova I. “I never understood what it was…” Experiences of women with vulvar intraepithelial neoplasia.

Poster Presentation. 13 th Biennial Meeting of the International

Gynecologic Cancer Society. Prague, Czech Republic, European Union.

23-26 October 2010

24. Carter J , Philp S, Arora V. Extended experience with an enhanced surgical recovery program. Poster Presentation. 13 th Biennial Meeting of the International Gynecologic Cancer Society. Prague, Czech Republic,

European Union. 23-26 October 2010

25. Lubotsky F, Butow P, Nattress K, Carter J , Milross C, Carroll S, Kwong C,

Philp S, Juraskova I. Recovering after pelvic radiation therapy: A pilot study of an information booklet to help women with gynaecological cancer,

Poster Presentation, 13th Biennial Meeting International Gynaecological

Cancer Society, Prague, Czech Republic, October 2010.

26. Juraskova I, Bonner C, Heruc G, Anderson C, Nattress K, Beale P, Carter

J. Helping women make informed treatment choices: Decision aids for two stages of ovarian cancer. Presentation, The 13 th Biennial Meeting of the

International Gynecologic Cancer Society (IGCS 2010), Prague, October

2010.


J . Improving decision-making in ovarian cancer: Development and evaluation of decision aids to help women make informed treatment choices. Poster Presentation, The Bi-annual Scientific Meeting of the

European Association for Communication In Healthcare (EACH), Verona,

September, 2010.

28. Juraskova I, Bonner C, Heruc G, Anderson C, Nattress K, Carter J .

Improving decision-making in ovarian cancer: Development and evaluation of decision aids to help women make informed treatment choices. Paper Presentation, The 8 th Interdisciplinary Conference on

Communication, Medicine & Ethics (COMET), Boston, June 2010.


Improving decision-making in ovarian cancer: Development and evaluation of decision aids to help women make informed treatment choices. Paper Presentation, The 12 th World Congress of the International

Psycho-Oncological Society (IPOS), Quebec City, June 2010.

30. Lubotsky F, Nattress K, Butow P, Carter J , Milross C, Caroll S, Kwong C,

Philp S, Juraskova I. Just the tool I needed: A pilot of an information booklet for women recovering from radiotherapy for gynaecological or anorectal cancer. Cancer Survivorship and Sexual Health Symposium.

Washington DC. United States of America. 17 th -19 th June 2011

31. Bonner C, Juraskova I, Nattress K, Anderson C, Milross C, Philp S, Carter

J . Barriers and facilitators affecting dilator use after pelvic radiotherapy for gynaecological cancer: the patient perspective. Multinational Association

Jonathan Carter, M.D., Page 17 of Supportive Care in Cancer (MASCC) International Conference, Athens,

Greece, June 2011 (Poster)


Improving shared decision making in ovarian cancer: the development and evaluation of two decision aids. The 6 th International Shared Decision

Making (ISDM) Conference, Maastricht, The Netherlands, June 2011 (Oral

Presentation)

33. Juraskova I, Bonner C, Heruc C, Anderson C, Nattress K, Carter J.

Helping Women With Ovarian Cancer Make Difficult Treatment Decisions:

The Development And Evaluation Of Two Decision Aids. Multinational

Association of Supportive Care in Cancer (MASCC) International

Conference, Athens, Greece, June 2011 (e-Poster & Standard Poster)

34. Lubotzky F, Juraskova I, Nattress K, Philp S, Milross C , Carter J.

Improving communication about post-radiotherapy adjustment: A pilot of an information booklet for women with gynaecological or colorectal cancer. Poster presentation at the Multinational Association of Supportive

Care in Cancer (MASCC) International Conference, Athens. 23-26 June

2011

35. Lubotsky F, Nattress K, Butow P, Carter J , Milross C, Caroll S, Kwong C,

Philp S, J uraskova I “Just the tool I needed’: A pilot of an information booklet for women recovering from radiotherapy for gynaecological or anorectal cancer. Moderated Poster Presentation, Cancer Survivorship and Sexual Health Symposium. Washington, USA. 17-19 June 2011

36. Nattress K, Dezarnaulds G, Carter J , Beale P, Milross C, Dalrymple C,

Pather S. Enhancing fertility preservation in women with gynaecological cancer. Poster presentation at the Cancer Survivorship and Sexual Health

Symposium. Washington DC USA. 17-19 June 2011.

37. Lubotzky F, Juraskova I, Nattress K, Philp S, Milross C, Carter J.

Improving Communication About Post-Radiotherapy Adjustment: A Pilot

Of An Information Booklet For Women With Gynaecological Or Colorectal

Cancer. Multinational Association of Supportive Care in Cancer (MASCC)

International Conference, Athens, Greece, June 2011 (e-Poster &

Standard Poster)

38. Taylor J, Juraskova I, Lobb E, Dalrymple C, Carter J . Experiences Of

Women With Vulvar Intraepithelial Neoplasia (Vin): A Qualitative Insight.

Multinational Association of Supportive Care in Cancer (MASCC)

International Conference, Athens, Greece, June 2011 (e-Poster &

Standard Poster)

39. Carter J . Invited Speaker AGES XXII Annual Scientific Meeting 2012 in association with the Asia Pacific Association for Gynecologic Endoscopy

(APAGE) Regional Meeting. Risk reducing strategies for hereditary and high risk ovarian cancer. Hilton Hotel Sydney Australia 1 st June 2012

40. Carter J . Invited Speaker 11 th International Congress of the Jordanian

Society of Obstetricians and Gynaecologists. Risk reducing strategies for hereditary and high risk ovarian cancer. Le Royal Hotel Amman Jordan

26 th -29 th September 2012

41. Carter J.

Invited Speaker 11 th International Congress of the Jordanian

Society of Obstetricians and Gynaecologists. An overview of cancer of the uterine corpus. Le Royal Hotel Amman Jordan 26 th -29 th September 2012

42. Carter J . Invited Speaker 11 th International Congress of the Jordanian

Society of Obstetricians and Gynaecologists. Cervical cancer screening

Jonathan Carter, M.D., Page 18 and management of the abnormal pap smear. Le Royal Hotel Amman

Jordan 26 th -29 th September 2012

National Presentations

1. Moradi M, Carter JR. Carson L, Elg S, Olson M, Twiggs L, Ramakrishan

S. Serum and ascites levels of IL-1 alpha, IL-1 beta and TNF-alpha in ovarian cancer. Oral presentation by first author, Western Association of

Gynecologic Oncologists 19th Annual Meeting; Newport, California 5th-8th

June 1991.

2. Carter JR. Adcock L, Prem K, Carson L, Twiggs L. Transvaginal color flow Doppler and the detection of pelvic malignancies. Poster presentation

23rd Annual Meeting Society of Gynecologic Oncologists, San Antonio

Texas 15th-18th March 1992.

3. Moradi M, Carson L, Carter JR. Twiggs L, Adcock L, Prem K, Brooker D.

Translocation of microbial organisms to pelvic lymph nodes as a possible cause of postoperative infection in gynecologic oncology patients.

Presentation 23rd Annual Meeting Society of Gynecologic Oncologists,

San Antonio, Texas 15th-18th March 1992.

4. Carter JR. Fowler J, Carlson J, Carson L, Adcock L, Twiggs L. Prediction of malignancy using transvaginal color flow Doppler in patients with gynecologic tumors. Presentation 21st Annual Meeting of The Western

Association of Gynecologic Oncologists, Santa Monica, California 20th-

23rd May 1993.

5. Carter JR. Fowler J, Carlson J, Carson L, Twiggs L. Transvaginal sonography of uterine tumors. Assessment of gray scale and color flow

Doppler results. Presentation 21st Annual Meeting of The Western


23rd May 1993.


Twiggs L. Lymph node yield from laparoscopic lymphadenectomy in cervical cancer: a comparative study. Poster presentation 24th Annual

Meeting The Society of Gynecologic Oncologists, Palm Desert, California

7th-10th February 1993.


Carson L, Twiggs L. Flow characteristics in benign and malignant gynecologic tumors using transvaginal color flow Doppler. Oral presentation 25th Anniversary Meeting, The Society of Gynecologic

Oncologists 6th-9th February 1994.

8. Carter JR. Fowler J, Carlson J, Adcock L, Carson L, Twiggs L.

Transvaginal sonography and color flow Doppler in the assessment of gestational trophoblastic disease. Poster presentation 25th Anniversary

Meeting, The Society of Gynecologic Oncologists. Orlando Florida 6th-9th

February 1994.


Carson L, Twiggs L. Flow characteristics in benign and malignant gynecologic tumors using transvaginal color flow Doppler. Oral presentation 12th Annual Australian Society Gynaecological Oncologists

Meeting, Bowral, NSW 6th-9th February 1994.

10. Engeler G, Carter JR. Dusenbery K. Radiation alone versus radiation and chemotherapy for unresectable vulvar cancer. Presentation 80th Annual


Radiologic Society of North America Meeting. Chicago, Illinois November

1994.

11. Fowler J, Hartenbach E, Reynolds H, Borner J, Carter JR. Carlson J,

Twiggs L, Carson L. Pelvic adhesion formation after pelvic lymphadenectomy: comparison between transperitoneal laparoscopy and extraperitoneal laparotomy in a porcine model. Poster presentation 25th

Anniversary Meeting, The Society of Gynecologic Oncologists. Orlando

Florida 6th-9th February 1994.

12. Saltzman A, Carter JR. Fowler J, Julian S, Carlson J, Hartenbach E,

Carson L, Twiggs L. The utility of preoperative screening colonoscopy in gynecologic oncology. Poster presentation 25th Anniversary Meeting, The

Society of Gynecologic Oncologists. Orlando Florida 6th-9th February

1994.

13. Chen M, Carter JR. Abrams J, Johnson P, Saltzman A, Fowler J, Twiggs

L, Carson L. Invasive hemodynamic monitoring for the assessment and optimization of the cardiovascular status in patients undergoing gynecologic oncology surgery. Poster presentation at 26th Annual

Meeting, The Society of Gynecologic Oncologists 1995.

14. Hartenbach E, Saltzman A, Carter JR. Nazarian G, Carlson J, Fowler J,

Twiggs L, Carson L. Nonsurgical management strategies for the functional complications of ileocolonic continent urinary reservoirs. Presentation 26th

Annual Meeting The Society of Gynecologic Oncologists 1995.

15. Twiggs L, Carter JR. Fowler J, Carson L, Herrick W, Carlson L, Potish R.

An estimation of resource utilization with the introduction of laparoscopic pelvic lymphadenectomy prior to radical hysterectomy in early cervical carcinoma: a progress report from the laparoscopic study group at the

Women's Cancer Center at the University of Minnesota Health Science

Center. Presentation The American Gynecologic Obstetric Society

(AGOS) Meeting, Napa Valley, California. 7th-10th September 1995.

16. Carter JR. Johnson P, Saltzman A, Chen M, Carney P, Hartenbach E,

Fowler J, Carson L, Twiggs L. Lack of adverse effect on quality of life of up to 6 cycles of chemotherapy in gynecologic cancer patients. Poster

Presentation 27th Annual Meeting of The Society of Gynecologic

Oncologists. New Orleans, Louisiana 11th-14th February 1996.


Fowler J, Carson L, Twiggs L. Lack of adverse effect on quality of life of up to 6 cycles of chemotherapy in gynecologic cancer patients. Oral presentation 12th Annual Australian Society Gynaecological Oncologists

Meeting, Bowral, NSW 9th-12th May 1996.


Fowler J, Carson L, Twiggs L. Lack of adverse effect on quality of life of up to 6 cycles of chemotherapy in gynecologic cancer patients. Oral presentation 1996 Annual Scientific Meeting, The Royal Australian

College of Obstetricians and Gynaecologists. Nadi Fiji 30th June- 5th July

1996.

19. Chen M, Carney P, Johnson P, Carter JR. Fowler J, Dusenbery K,

Mitchell S, Carson L, Potish R, Twiggs L. Phase I trial of weekly taxol as a radiation sensitizer in advanced cervical cancer. Presentation Western

Association of Gynecologic Oncologists, 24th Annual Meeting, San Diego,

CA 29th May-1st June 1996.


20. Cosin J, Carney P, Carter JR. Chen M, Johnson P, Fowler J, Twiggs L,

Carson L. A simplified method for detubularization in the construction of a continent ileocolic reservoir (Miami pouch). Presentation Western


CA 29th May-1st-June 1996.

21. Gordon A, Bookman M, Malmstrom H, Bolis G, Mangioni C, Hall J, Carter

JR. Hudson I, Broom C. Efficacy of Topetecan in advanced epithelial ovarian cancer after failure of platinum and paclitaxel. International

Topotecan Study Group Trial. Presentation 32nd Annual Meeting

American Society of Clinical Oncology, Philadelphia, PA 18th-21st May

1996.

22. MacLeod C, Fowler A, Dalrymple C, Atkinson K, Elliott P, Carter JR. High dose rate brachytherapy in the management of high grade intraepithelial neoplasia of the vagina. Presentation 12th Annual Australian Society

Gynaecological Oncologists Meeting, Bowral, NSW 9th-12th May 1996.

23. Saltzman A, Carter JR. Contreras D, Hartenbach E, Fowler J, Carson L,

Twiggs L. Total pelvic exenteration: the relationship between management of the pelvic floor and post-operative complications. Presentation Western


CA 29th May- 1st June 1996.

24. Carter JR. Cosin J, Carney P, Chen M, Johnson P, Fowler J, Twiggs L,

Carson L. A simplified method for detubularization in the construction of a continent ileo-colic reservoir (Miami Pouch). Oral presentation 12th Annual

Meeting of the Australian Society of Gynaecologic Oncologists. Noosa,

Queensland 2nd-5th May 1997.

25. Carter JR. Evaluation of the adnexal mass: implications for laparoscopic surgery. Presentation VII Annual Scientific Meeting, Australian

Gynaecological Endoscopy Society Meeting. Sydney Australia 31st July-

2nd August 1997.


Mitchell S, Carson L, Twiggs L. Phase I trial of weekly Taxol as a radiation sensitizer in advanced cervical cancer. Oral Presentation 28th Annual

Meeting of The Society of Gynecologic Oncologists. Phoenix Arizona

22nd-26th March 1997.

27. Cooper M, Wong F, Carter JR. Initial experience of laparoscopic pelvic lymphadenectomy. Presentation VII Annual Scientific Meeting, Australian

Gynaecological Endoscopy Society Meeting. Sydney Australia 31st July-

2nd August 1997.

28. Macleod C, Fowler A, Dalrymple C, Atkinson K, Carter JR. High dose rate brachytherapy in the primary management of cervical cancer. An 8 year

Australian experience. Presentation 12th Annual Meeting of the Australian

Society of Gynaecologic Oncologists. Noosa, Queensland 2nd-5th May

1997.

29. Bucci J, MacGibbon A, Carter JR. MacLeod C, Solomon J, Firth I. Whole abdominal radiotherapy (WAR) after surgical debulking, chemotherapy and second look laparotomy for advanced ovarian carcinoma: Phase I/II trial. Oral and poster presentation 1998 Winter Meeting Medical Oncology

Group and Faculty of Radiation Oncology, The Royal Australian College of

Radiologists Meeting, Queenstown New Zealand, 12th-15th August 1998.

30. Carter JR. Cervical tumour characterization by transvaginal colour flow

Doppler ultrasound. Presentation 13th Annual Meeting of the Australian


Society of Gynaecologic Oncologists, Freycinet Lodge, Coles Bay,

Tasmania 23rd-26th April 1998.

31. Carter JR. Cervical tumour characterization by transvaginal colour flow

Doppler ultrasound. Presentation 28th Annual Scientific Meeting of

Australasian Society for Ultrasound in Medicine. Melbourne, Victoria 4th-

6th September 1998.

32. MacLeod C, Fowler A, Dalrymple C, Carter JR. Posthysterectomy high dose rate brachytherapy alone for endometrial cancer. Presentation 13th

Annual Meeting of the Australian Society of Gynaecologic Oncologists,

Freycinet Lodge, Coles Bay, Tasmania 23rd-26th April 1998.

33. Carter JR. Gynaecologic tumour surveillance: possible role for transvaginal sonography. Oral presentation 29th Annual Scientific

Meeting, Australian Society for Ultrasound in Medicine. Adelaide

Convention Centre, Adelaide, South Australia 17th-19th September 1999.

34. Carter JR. Whole abdominal radiotherapy following second look laparotomy for ovarian cancer. Presentation 15th Annual Scientific

Meeting, Australian Society of Gynaecologic Oncologists. South Australia

5th - 9th April 2000.

35. Valmadre S, Carter JR. Dalrymple J. Conservative management of large bowel obstruction in patients with ovarian cancer using intraluminal rectal stents. Presentation 16th Annual Scientific Meeting, Australian Society of

Gynaecologic Oncologists. Victoria 26th - 29th April 2001.

36. Carter JR. Analysis of clinicopathologic factors in malignant mixed

Mullerian tumours of the uterine corpus. Oral presentation 17th Annual

Scientific Meeting Australian Society of Gynaecologic Oncologists.

Broome, Western Australia 22nd - 26th May 2002.

37. Carter JR. Laparoscopy in gynaecological oncology: we can but should we? Oral presentation 17th Annual Scientific Meeting Australian Society of

Gynaecologic Oncologists. Broome, Western Australia 22nd - 26th May

2002.

38. Carter JR, Sim J, Pather S, Dalrymple C, Land R, Abdel-Hadi M.

Recurrence after treatment for high grade cervical dysplasia. Oral presentation 20th Annual Scientific Meeting Australian Society

Gynaecologic Oncologists . Port Douglas, Queensland. 29 th June-3 rd July

2005.

39. Carter JR , Sim J, Pather S, Dalrymple C, Land R, Abdel-Hadi M.

Recurrence after treatment for high grade cervical dysplasia: should we modifiy our posttreatment surveillance protocols? Oral Presentation.

Australian Society of Colposcopy and Cervical Pathology. XIX Annual

Scientific Meeting 2005.

40. Culling B, Hamilton A, Andrews L, Nattress K, Carmalt H, Carter J . One year review of the Sydney Cancer Centre Breast and Ovarian Cancer Risk

Management Clinic. Poster Presentation. A combined meeting of kConFab, Australian Ovarian Cancer Study (AOCS), ACCFS & Family

Cancer Clinics of Australia and New Zealand 2005;Couran Cove Island

Resort. 30th August - 3rd September, 2005.

41. Russell P, Dray M, Dalrymple C, Carter J . P16 immunostaining of colposcopically directed cervical biopsies. Oral presentation. Australian

Society of Colposcopy and Cervical Pathology. XIX Annual Scientific

Meeting 2005.


42. Rao A, Pather S, Abdel-Hadi M, Dalrymple C, Mackie A, Carter J . HPV

DNA testing in patients with inconclusive Pap smears. Oral Presentation.

20th Annual Scientifc Meeing Australian Society of Gynaecologic

Oncologists 2006.

43. O'Leary M, Abdel-Hadi M, Pather S, Carter J , Dalrymple C. The effects of the National Cervical Screening Programme on cervical cancer in young women. Oral Presentation 20th Annual Scientifc Meeing Australian

Society of Gynaecologic Oncologists 2006.

44. Nattress K, White K, Philp S, Carter JR

& Beale P (2007) ‘Survivorship

Issues for Women with Ovarian Cancer’, oral presentation at 28th Medical

Oncology Group of Australia Annual Scientific Meeting & 10th Winter

Congress of the Cancer Nurses Society of Australia, Melbourne.

 

45. Pham TT, Carter JR , Jackson M, Dalrymple C, Atkinson K, Pather S,

Milross C. High dose rate (HDR) vaginal vault brachytherapy, following hysterectomy and surgical staging for early stage endometrial cancer.

Presented by 1 st author at RANZCR Annual Scientific Meeting. Adelaide

16th October 2008.

46. Carter JR.

An overview and appraisal of recent advances and controversies in ovarian cancer management. Malaysian Oncology

Society Annual Scientific Meeting. Kota Kinabalu, Sabah Malaysia 16 th -

19 th October 2008

47. Carter JR.

An overview and appraisal of recent advances and controversies in corpus cancer management. Malaysian Oncology Society

Annual Scientific Meeting. Kota Kinabalu, Sabah Malaysia 16 th -19 th

October 2008

48. Anderson C, Juraskova I, Harrison J, Beale P, Nattress K, Philp S &

Carter JR . When there is no evidence to guide: The development and pilot of a Decision Aid to improve communication and decision making about treatment options for asymptomatic ovarian cancer patients with rising CA-125. Poster presentation. COSA ASM, Sydney, 19 th November

2008.

49. Gainford MC, Tinker A, Carter JR, Petru E, Nicklin J, Quinn M, Hammond

I, Elit M, Lenhard M, Friedlander M. Malignant transformation within ovarian dermoid cysts. An audit of treatment received and patient outcomes. A gynaecologic cancer intergroup (GCIG) study. Abstract submitted ASCO 2009

50. Carter JR.

Neoplastic changes in the endometrium.

RANZCOG/NSW/ACT Registrar Education Day. 27 th February 2009.

51. Anderson C, Juraskova I, Harrison J, Beale P, Nattress K, Philp S, Carter

J.

Where there is no evidence to guide: the development and pilot of a decision aid to improve communication and decision making about treatment options for asymptomatic ovarian cancer patients with rising

CA125. Inaugural Joint Conference Australian New Zealand

Gynaecological Oncology Group and Austalian Society of Gynaecological

Oncologists. Noosa Sheraton Resort and Spa. 1-5 April 2009.

52. Juraskova I, Nattress K, Anderson C, Lubotzky F, Carter J.

The good, the bad and the dilator: information needs and acceptance of vaginal dilators following radiation for gynaecological cancer. Inaugural Joint Conference

Australian New Zealand Gynaecological Oncology Group and Austalian

Society of Gynaecological Oncologists. Noosa Sheraton Resort and Spa.

1-5 April 2009.


53. Tai D, Atkinson K, Dalrymple C, Pather S, Philp S, Nattress K, Carter J.

A prospective study on patient satisfaction with the Oncology/Dysplasia

Service at the Sydney Cancer Centre. Inaugural Joint Conference



1-5 April 2009.

54. Carter J , Szabo R, Sim, W, Philp S, Nattress K, Dalrymple C, Pather S.

Fast track surgery in gynaecological oncology. A clinical audit. Inaugural

Joint Conference Australian New Zealand Gynaecological Oncology

Group and Austalian Society of Gynaecological Oncologists. Noosa

Sheraton Resort and Spa. 1-5 April 2009.

55. Nattress K, Carter J , Beale P, Philp S, Knight C, White K. Do current follow up practices meet the needs of gynaecological cancer survivors?

Inaugural Joint Conference Australian New Zealand Gynaecological

Oncology Group and Austalian Society of Gynaecological Oncologists.

Noosa Sheraton Resort and Spa. 1-5 April 2009.

56. Ding Z, Jiang C, Pather S, Dalrymple C, Atkinson K, Murali R, Al-Rayyan

E, Luo K, Carter J . The outcome of cervical intraepithelial neoplasia 2 diagnosed by punch biopsy in 131 women. Oral Presentation. 21 st

Australian Society for Colposcopy and Cervical Pathology (ASCCP)

Crowne Plaza Hotel Darwin Northern Territory 13-16 August 2009

57. Carter J, Philp S, Arora V, Smirnova S, Patel P, Nattress K, Pather S,

Dalrymple C, Cotterell S. Discharge on Postop Day 2 after Major

Gynaecological Surgery. Is it Possible? Oral Presentation 25 th Annual

Scientific Meeting Australian Society of Gynaecological Oncologists.

Bunker Bay Western Australia 23-28 th March 2010

58. Bonner C, Nattress K, Carter J , Anderson C, Juraskova I. Turning a

“chore” into a “priority”: Barriers and facilitators affecting vaginal dilator use after pelvic radiation therapy for gynaecological cancer. Poster presentation The 36th Annual Scientific Meeting of the Clinical

Oncological Society of Australia (COSA), Melbourne, 9-11 November

2010 (Poster - short listed for the Best of the Best Poster Presentation

Award).

59. Taylor J, Lobb E, Dalrymple C, Carter J

, Juraskova I. “I never understood what it was…” Experiences of women with vulvar intraepithelial neoplasia.

Poster presentation The 36th Annual Scientific Meeting of the Clinical

Oncological Society of Australia (COSA), Melbourne. 9-11 November

2010.


Development and evaluation of two new decision aids to help women with ovarian cancer make informed treatment decisions. Poster Presentation,

The 36th Annual Scientific Meeting of the Clinical Oncological Society of

Australia (COSA), Melbourne, November 2010.


J.

Decision-Making in Ovarian Cancer: Developing and evaluating practical tools to help women make informed treatment choices.

Presentation The Australia New Zealand Gynecological Oncology Group

(ANZGOG) Conference, Noosa, February 2010.

62. Pather S, Loadsman J, Gopalan D, Rao A, Philp S, Carter J . The role of a transversus abdominis plane block in patient undergoing total laparoscopic hysterectomy.A retrospective review. Ages Scientific Meeting


2011. Risks and disaster Recovery. 27.03.11. Crown Towers, Melbourne,

Australia.

63. Carter J , Philp S. Am I doing what I think I am doing? A clinical audit assessing outcomes after fast track surgical management of corpus cancer. Australian Society of Gynaecologic Oncologists 26 th Annual

Scientific Meeting. Millbrook Queenstown New Zealand. 6 th to 9 th July

2011

64. Rao A, Pather S, Philp S, Carter J . A case controlled study comparing total laparoscopic hysterectomy and fast track open hysterectomy in a gynaecological oncology unit. Australian Society of Gynaecologic

Oncologists 26 th Annual Scientific Meeting. Millbrook Queenstown New

Zealand. 6 th to 9 th July 2011

65. Carter J , Philp S. Program development and extended experience with a fast track surgery program. Australian Society of Gynaecologic



66. Philp S, Carter J , Pather S, White K Fast track surgery and nurseled follow up in gynaecological oncology: A new model of care, Oral

Presentation, Cancer Nurse’s Society of Australia 14 th Winter

Congress, Sydney, Australia, July 2011

67. Lubotsky F, Nattress K, Butow P, Carter J , Milross C, Caroll S, Kwong

C, Philp S,

Juraskova I “Just the tool I needed’: A pilot of an information booklet for women recovering from radiotherapy for gynaecological or anorectal cancer, Poster Presentation, Cancer Survivorship and

Sexual Health Symposium, Washington, USA, June 2011

68. Carter JR.

Invited Speaker. Recent developments in the diagnosis and management of epithelial ovarian cancer. Australian Association of

Clinical Biochemists 49 th Annual Scientific Conference. Sydney

Convention Centre, Sydney 10 th -13 th October 2011.

69. Lubotzky F, Juraskova I, Nattress K, Philp S, Carroll S, Milross C, Carter

J.

Improving communication about recovery following pelvic radiation: A pilot of an information booklet for women with gynaecological or anorectal cancer. The 38th Annual Scientific Meeting of the Clinical Oncological

Society of Australia (COSA), Perth, November 2011 (Poster)


Pather S. Enhancing fertility preservation in women with gynaecological cancer. Poster presentation at the 38th Annual Scientific Meeting of the

Clinical Oncological Society of Australia (COSA), Perth. 15-17 November

2011.

71. Richards A, Pather S, Rome P, Carter J . Complex Vulval Defects: A single institution experience of a novel reconstruction technique

–The

Modified Singapore Flap. Australiasian Society of Gynaecology Oncology

Annual Scientific Meeting 4 th -7 th July 2013, Darwin Australia.

72. Al-Aker M, Pather S, Gibson S, Carter J . Preoperative use of Gabapentin as an adjuvant to postoperative analgesia in women undergoing laparotomy for treatment of malignant or suspected malignant gynaecologic diseases.

28th ASGO Scientific Meeting, 4 th -7 th July 2013,

Darwin. Australia.

73. Blain G, Pather S, Richards A, Carter J, Saidi S. Outcomes for women presenting with high grade pap smears: Implications for “see and treat”.


Oral presentation Combined ANZGOG/ASGO ASM. Canberra 26-29

March 2014

74. Nagrial A, Long A, Chin V, Carter J , Beale P. Duration of systemic therapy for ovarian cancer: a systematic review and meta-analysis. Oral presentation Combined ANZGOG/ASGO ASM. Canberra 26-29 March

2014

75. Farrell R, Carter J , Dixon S, Webb P. Lymphadenectomy in early stage high-risk endometrial cancer: clinical characteristics and outcomes in an

Australian cohort. Oral presentation Combined ANZGOG/ASGO ASM.

Canberra 26-29 March 2014

76. Nagrial A, Chin V, Carter J , Beale P. Duration of systemic therapy for ovarian cancer: A systematic review and meta-analysis. Oral presentation

77.

ASCO. 2014

State Presentations

1. Carter JR. Proliferating and invasive epithelial ovarian tumours in young women. Presentation New South Wales and Queensland Scientific

Meeting, Wagga Wagga, N.S.W 1st-2nd October 1988.

2. Carter JR. Management of the abnormal pap smear. Presentation State of Minnesota Family Practice Review: Update 1991; Minneapolis,

Minnesota 22nd-26th April 1991.

3. Carter JR. Transvaginal ultrasound in ovarian cancer screening.

Presentation Eighth Annual Symposium on Gynecologic Oncology;

Minneapolis, Minnesota 14th May 1991.

4. Carter JR. Ovarian cancer screening. Presentation Minnesota State

Obstetrical and Gynecological Society Meeting, Brainerd, Minnesota 22nd

June 1991.

5. Carter JR. Transvaginal ultrasound for the gynecologist. Presentation

Department of Obstetrics and Gynecology, University of Cincinnati

College of Medicine. Cincinnati, Ohio 22nd September 1991.

6. Carter JR. Ovarian Cancer Screening. Presentation Department of

Obstetrics and Gynecology, University of Cincinnati College of Medicine.

Cincinnati, Ohio 22nd September 1991.

7. Carter JR. Fowler J, Carlson J, Adcock L, Carson L, Twiggs L. A comparative study of benign and malignant tumors using transvaginal color flow Doppler. Presentation The Society of Memorial Gynecologic

Oncologists Fifteenth Annual Meeting, Dearborn, Michigan 7th-10th

October 1992.

8. Carter JR. Fowler J, Carlson J, Adcock L, Carson L, Twiggs L. A comparative study of benign and malignant tumors using transvaginal color flow Doppler. Presentation The Minnesota State Obstetrical and

Gynecological Society Meeting. Minneapolis, Minnesota 5th December

1992.

9. Carter JR. Ovarian cancer screening. Presentation Grand Rounds

University of Hawaii, Kapiolani Medical Center. Honolulu Hawaii 19th

February 1993.

10. Carter JR. Minimally invasive surgery for the gynecologist. Presentation

Annual Meeting of the Minnesota Chapter of the American College of

Surgeons. Minneapolis Minnesota 6th November 1993.



Twiggs L. Pelvic adhesion formation after pelvic lymphadenectomy; a comparison between transperitoneal laparoscopy and extraperitoneal laparotomy in a porcine model. Presentation ACOG District 6 Junior

Fellow Meeting. Milwaukee, Wisconsin 17th September 1993.

12. Saltzman A, Fowler J, Carlson J, Carter JR. Hartenbach E, Carson L,

Twiggs L. Laparoscopic pelvic and paraaortic lymphadenectomy: the

University of Minnesota experience. Presentation 32nd Annual Meeting

Armed Forces District, The American College of Obstetricians and

Gynecologists. Seattle Washington 30th October-3rd November 1993.

13. Carlson J, Fowler J, Saltzman A, Carter JR. Chen D, Mitchell S, Dunn D,

Carson L, Adcock L, Twiggs L. Chemoprophylaxis with oral ciprofloxacin in ovarian cancer patients receiving Taxol. Presentation 22nd Annual

Meeting of The Western Association of Gynecologic Oncologists.

Whistler, British Columbia, Canada 22nd-25th June 1994.

14. Carlson J, Nazarian G, Hartenbach E, Carter JR. Dusenbery K, Fowler J,

Hunter D, Adcock L, Twiggs L, Carson L. Management of pelvic venous stenosis with intravascular metal stents: an alternative for the gynecologic patient. Presentation 22nd Annual Meeting of The Western Association of

Gynecologic Oncologists. Whistler, British Columbia, Canada 22nd-25th

June 1994.

15. Carter JR. Saltzman A, Chen M, Carney P, Johnson P, Hartenbach E,

Fowler J, Carson L, Twiggs L. Quality of life assessment in gynecologic cancer patients: a preliminary report. Presentation 23rd Annual Meeting of The Western Association of Gynecologic Oncologists. Coeur d'Alene,

Idaho 7th-10th June 1995.

16. Chen M, Fowler J, Carter JR. Saltzman A, Johnson P, Hartenbach E,

Carney P, Carson L, Twiggs L. Radical hysterectomy for early stage cervical cancer: lymph node status and patterns of recurrence.

Presentation 23rd Annual Meeting of The Western Association of

Gynecologic Oncologists. Coeur d'Alene, Idaho 7th-10th June 1995.

17. MacGibbon A, Bucci J, Solomon H, MacLeod C, Carter JR. Whole abdominal radiotherapy following second look laparotomy for ovarian carcinoma. Presentation NSW/QLD State Committees Combined ASM

3rd October 1998.

18. Carter JR. Management of haemorrhage in gynaecologic surgery.

Presentation MRANZCOG Pre-Exam Course. Northern Sydney Education

Centre, Macquarie Hospital, North Ryde 13th November 2000.

19. Carter JR. Management of haemorrhage in gynaecological surgery.

Presentation MRANZCOG Pre-Exam Course Northern Sydney Education

Centre, Macquarie Hospital, North Ryde 26th-30th November 2001.

20. Carter JR. Gynaecology for general surgeons. Chairman General Surgical

Training Course Programme Johnson & Johnson Education Institute,

Ryde NSW 4th July 2001.

21. Carter JR. Overview of gynaecological cancers. Presentation The New

South Wales College of Nursing 14th October 2002.

22. Carter JR. Overview of gynaecological cancers. Presentation The New

South Wales College of Nursing 12th August 2002.





24. Carter JR. Endometrial cancer: current management. Presentation

RANZCOG NSW State Committee Registrar Training Symposia. Royal

Prince Alfred Hospital 21st June 2002.


Presentation MRANZCOG Pre-Exam Course. Twin Towers Inn, Artarmon.

24th November 2003.


Presentation MRANZCOG Pre-Exam Course. Mercure Hotel, St Leonards

8th November 2004.

27. Carter JR. Advances in surgery in gynaecological oncology. Presentation

Gynaecological Oncology CNC Network Study Day. Royal Hospital for

Women 12th March 2004.

28. Carter JR. Gynaecologial cancer-screening and diagnosis. Presentation

RANZCOG Update in Office Gynaecology and Obstetrics for GP’s.

Macquarie Hospital, North Ryde. 18th January 2005.

29. Carter JR.

Gestational trophoblastic disease. Presentation at NSW

Gyna ecological Oncology CNC Network Seminar “Current Issues in

Gynaecological Oncology Nursing”. 26 th May 2005

30. Carter JR . Updates in Practice. Oncology. Presentation The Combined

New South Wales/Queensland Annual Scientific Meeting 11th-12th June

2005.

31. Carter JR . Management of haemorrhage in gynaecologic surgery.

Presentation MRANZCOG Pre-Exam Course. Rydges Hotel, North

Sydney 2005.

Abstracts

1. Carter JR. Atkinson K, Coppleson M, Elliott P, Murray J, Solomon J,

Dalrymple C, Tattersall M, Duval P, Russell P, Bannatyne P. A comparative study of proliferating and invasive epithelial ovarian tumours in young women. Book of abstracts Royal College of Obstetricians and

Gynaecologists. Silver Jubilee British Congress of Obstetrics and

Gynecology. London, England 4th-7th July 1989.

2. Carter JR. Liver function in normal pregnancy. Abstracted into the bibliography of Current Opinion in Obstetrics and Gynecology 1991. Aust

NZ J Obstet Gynaecol 1990;30(4):265-302.

3. Carlson J, Carson L, Soisson A, Carter JR. Twiggs L. Rectus abdominus myocutaneous flap for neovaginal reconstruction. Book of abstracts The

Western Association of Gynecologic Oncologists Twentieth Annual

Meeting, page 26 Durango, Colorado 17th-20th June 1992.

4. Carlson J, Carson L, Soisson A, Carter JR. Twiggs L. Rectus abdominus myocutaneous flap for neovaginal reconstruction. Gynecol Oncol

1992;46(2):265.

5. Carter JR. Ramirez C, Waugh R, Atkinson K, Coppleson M, Elliott P,

Murray J, Solomon J, Dalrymple C, Tattersall M, Duval P, Russell P,

Lickiss N. Percutaneous urinary diversion in gynecologic oncology.

Selected as outstanding in its field by the editor. Ob Gyn Digest

1992;2:22-24.

6. Carter JR. Adcock L, Prem K, Carson L, Twiggs L. Transvaginal color flow Doppler and the detection of pelvic malignancies. 23rd Annual

Meeting of the Society of Gynecologic Oncologists. Gynecol Oncol

1992;45:76-111.


7. Carter JR. Fowler J, Carlson J, Adcock L, Carson L, Twiggs L. A comparative study of benign and malignant tumors using transvaginal color flow Doppler. Book of abstracts Fifth World Congress on

Transvaginal Sonography Orlando, Florida 8th-10th May 1992:150.

8. Carter JR. Adcock L, Prem K, Carson L, Twiggs L. Transvaginal color flow Doppler and the detection of pelvic malignancies. Abstracted in

Obstetrics and Gynecology News, International Medical News Group June

1992.

9. Carter JR. Fowler J, Carlson J, Adcock L, Carson L, Twiggs L. A comparative study of benign and malignant tumors using transvaginal color flow Doppler. Book of abstracts The Society of Memorial

Gynecologic Oncologists Fifteenth Annual Meeting Dearborn, Michigan

7th-10th October 1992.

10. Moradi M, Carson L, Carter JR. Twiggs L, Adcock L, Prem K, Brooker D.

Translocation of microbial organisms to pelvic lymph nodes as a possible cause of postoperative infection in gynecologic oncology. Abstract 23rd

Annual Meeting of the Society of Gynecologic Oncologists. Gynecol Oncol

1992;45:76-111.

11. Byers L, Carter JR. Carlson J, Fowler J, Adcock L, Carson L, Twiggs L.

Invasive cervical cancer diagnosed initially at the time of simple hysterectomy: a comparison of radiation therapy versus radical surgery.

Book of abstracts 21st Annual Meeting of The Western Association of

Gynecologic Oncologists, Santa Monica, California 20th-23rd May 1993.

12. Byers L, Carter JR. Carlson J, Fowler J, Adcock L, Carson L, Twiggs L.

Invasive cervical cancer diagnosed initially at the time of simple hysterectomy: a comparison of radiation therapy versus radical surgery.

Abstract. Gynecol Oncol 1993;50(272).

13. Carlson J, Saltzman A, Carter JR. Hartenbach E, Fowler J, Carson L,

Twiggs L. The versatility of the rectus abdominus flap in endopelvic and extra abdominal reconstruction. Book of abstracts 21st Annual Meeting of

The Western Association of Gynecologic Oncologists, Santa Monica,

California 20th-23rd May 1993.

14. Carlson J, Saltzman A, Carter JR. Hartenbach E, Fowler J, Carson L,

Twiggs L. The versatility of the rectus abdominis flap in endopelvic and extra abdominal reconstruction. Abstract. Gynecol Oncol 1993;50:266.

15. Carter JR. Fowler J, Carlson J, Carson L, Adcock L, Twiggs L. Prediction of malignancy using transvaginal color flow Doppler in patients with gynecologic tumors. Book of abstracts 21st Annual Meeting of The

Western Association of Gynecologic Oncologists, Santa Monica,

California 20th-23rd May 1993.


Doppler results. Book of abstracts 21st Annual Meeting of The Western


23rd May 1993.


Transvaginal sonography and color flow Doppler in the assessment of gestational trophoblastic disease. Abstract. Gynecol Oncol 1993;49:141.

18. Carter JR. Fowler J, Hartenbach E, Adcock L, Twiggs L, Carson L. In situ and invasive vulvar tumors in young women-a disease of the immunosuppressed? Abstract. Gynecol Oncol 1993;49:141.


19. Carter JR. Fowler J, Carlson J, Carson L, Adcock L, Twiggs L. Prediction of malignancy using transvaginal color flow Doppler. Abstract. Gynecol

Oncol 1993;50:270.


Twiggs L. Vulvar cancer in young women: a disease of the immunosuppressed ? Book of abstracts XIIth ISSVD Congress Quebec

Canada 27th-30th September 1993:12.

21. Carter JR. Fowler J, Carlson J, Carson L, LB T. Just how accurate is the pelvic examination? A prospective comparative study. Book of abstracts,

The III World Congress of Ultrasound in Obstetrics and Gynecology.

Ultrasound in Obstetrics and Gynecology 1993;3(2):33.


Carson L, Twiggs L. Flow characteristics in benign and malignant gynecologic tumors using transvaginal color flow Doppler. Abstract The III

World Congress of Ultrasound in Obstetrics and Gynecology. Ultrasound in Obstetrics and Gynecology 1993;3(2):34.

23. Carter JR. Fowler J, Carlson J, Carson L, Twiggs L. Prediction of malignancy using transvaginal color flow Doppler in patients with gynecologic tumors. Abstract. Ultrasound in Obstetrics and Gynecology

1993;3(2):35.

24. Carter JR. Carlson J, Fowler J, Carson L, Twiggs L. Invasive mole: diagnosis and surveillance with transvaginal sonography and color flow

Doppler. Abstract. Ultrasound in Obstetrics and Gynecology 1993;3(2):35.

25. Carter JR. Fowler J, Carlson J, Saltzman A, Byers L, Carson L, Twiggs L.

Transvaginal sonography and color flow Doppler in the assessment of gestational trophoblastic disease. Abstract. Ultrasound in Obstetrics and

Gynecology 1993;3(2):36.


Doppler results. Abstract. Ultrasound in Obstetrics and Gynecology

1993;3(2):37.


Twiggs L. Lymph node yield from laparoscopic lymphadenectomy in cervical cancer: a comparative study. Book of abstracts 24th Annual

Meeting The Society of Gynecologic Oncologists Palm Desert, California

7th-10th February 1993.


Twiggs L. Lymph node yield from laparoscopic lymphadenectomy in cervical cancer: a comparative study. Abstract. Gynecol Oncol

1993;49:128.

29. Carlson J, Fowler J, Carter JR. Saltzman A, Hartenbach E, Mitchell S,

Johnson P, Chen D, Dunn D, Carson L, Twiggs L. Chemoprophylaxis with ciprofloxacin (Cipro) in ovarian cancer patients receiving paclitaxel (Taxol).

Annual Meeting ASCO. Program and Proceedings #1641, Volume 13

14th-17th May 1994.

30. Carlson J, Fowler J, Saltzman A, Carter JR. Chen M, Mitchell S, Dunn D,

Carson L, Adcock L, Twiggs L. Chemoprophylaxis with oral ciprofloxacin in ovarian cancer patients receiving Taxol. Book of abstracts 22nd Annual

Meeting of The Western Association of Gynecologic Oncologists.

Whistler, British Columbia 22nd-25th June 1994.



Hunter D, Adcock L, Twiggs L, Carson L. Management of pelvic venous stenosis with intravascular metal stents: an alternative for the gynecologic patient. Book of abstracts 22nd Annual Meeting of The Western

Association of Gynecologic Oncologists. Whistler, British Columbia 22nd-

25th June 1994.

32. Carlson J, Fowler J, Saltzman A, Carter JR. Chen M, Mitchell S, Dunn D,

Carson L, Adcock L, LB T. Chemoprophylaxis with oral ciprofloxacin in ovarian cancer patients receiving Taxol. Abstract. Gynecol Oncol

1994;54:104-112.


Hunter D, Adcock L, Twiggs L, Carson L. Management of pelvic venous stenosis with intravascular metal stents: an alternative for the gynecologic patient. Abstract. Gynecol Oncol 1994;54:104-112.


Carson L, Twiggs L. Flow characteristics in benign and malignant gynecologic tumors using transvaginal color flow Doppler. Abstracted in

Ob Gyn Digest 1994;5(October):19-21.


Carson L, Twiggs L. Flow characteristics in benign and malignant gynecologic tumors using transvaginal color flow Doppler. Book of abstracts 25th Anniversary Meeting The Society of Gynecologic

Oncologists. Orlando Florida 6th-9th February 1994.


Transvaginal sonography and color flow Doppler in the assessment of gestational trophoblastic disease. Book of abstracts 25th Anniversary

Meeting The Society of Gynecologic Oncologists. Orlando Florida 6th-9th

February 1994.


Transvaginal sonography and color flow Doppler in the assessment of gestational trophoblastic disease. Abstracts presented for 25th Annual

Meeting of the Society of Gynecologic Oncologists. Gynecol Oncol

1994;52:102-149.


Carson L, Twiggs L. Flow characteristics in benign and malignant gynecologic tumors using transvaginal color flow Doppler. Abstracts presented for the 25th Annual Meeting of the Society of Gynecologic

Oncologists. Gynecol Oncol 1994;52:102-149.

39. Carter JR. Fowler J, Carlson J, Hartenbach E, Byers L, Saltzman A,

Mitchell S, Carson L, Twiggs L. Ovarian cancer in young women.

Abstracts presented for the 25th Annual Meeting of the Society of

Gynecologic Oncologists. Gynecol Oncol 1994;52:102-149.

40. Carter JR. Fowler J, Carlson J, Carson L, Twiggs L. Transvaginal sonography of uterine tumors: assessment of gray scale and color flow

Doppler results. Abstracts presented 25th Annual Meeting of the Society of Gynecologic Oncologists. Gynecol Oncol 1994;52:102-149.

41. Carter JR. Oakley G, Carlson J, Fowler J, Hartenbach E, Byers L, Adcock

L, Carson L, Twiggs L. A pilot study of alternating courses of cisplatin/cytoxan and carboplatin/etoposide in advanced ovarian cancer.

Abstracts presented for the 25th Annual Meeting of the Society of

Gynecologic Oncologists. Gynecol Oncol 1994;52:102-149.


42. Carter JR. Collected Letters. Screening of women for ovarian cancer with no family history of ovarian cancer. International Correspondence Society of Obstetricians and Gynecologists. 1994;35(3):1-8.

43. Engeler G, Carter JR. Dusenbery K. Radiation alone versus radiation and chemotherapy for unresectable vulvar cancer. Book of abstracts 80th

Annual Radiologic Society of North America Meeting. Chicago, Illinois

November 1994.


Twiggs L, Carson L. Pelvic adhesion formation after pelvic lymphadenectomy: comparison between transperitoneal laparoscopy and extraperitoneal laparotomy in a porcine model. Book of abstracts 25th

Anniversary Meeting, The Society of Gynecologic Oncologists, Orlando

Florida 6th-9th February 1994.


Twiggs L, Carson L. Pelvic adhesion formation after pelvic lymphadenectomy: comparison between transperitoneal laparoscopy and extraperitoneal laparotomy in a porcine model. Abstracts presented 25th

Annual Meeting of the Society of Gynecologic Oncologists. Gynecol Oncol

1994;52:102-149.

46. Saltzman A, Fowler J, Julian S, Carter JR. Carlson J, Hartenbach E,

Carson L, Twiggs L. The utility of preoperative screening colonoscopy in gynecologic oncology. Book of abstracts 25th Anniversary Meeting The

Society of Gynecologic Oncologists. Orlando Florida 6th-9th February

1994.

47. Saltzman A, Fowler J, Julian S, Carter JR. Carlson J, Hartenbach E,

Carson L, Twiggs L. The utility of preoperative screening colonoscopy in gynecologic oncology. Abstracts presented 25th Annual Meeting of the

Society of Gynecologic Oncologists. Gynecol Oncol 1994;52:102-149.

48. Carter JR. Lau M, Fowler J, Carlson J, Carson L, Twiggs L. Blood flow characteristics of ovarian tumors: implications for ovarian cancer screening. Abstract into series "New Directions in Patient Care" for Today in Medicine: Obstetrics and Gynecology 1995.


Fowler J, Carson L, Twiggs L. Quality of life assessment in gynecologic cancer patients: a preliminary report. Book of abstracts 23rd Annual

Meeting of The Western Association of Gynecologic Oncologists. Coeur d'Alene, Idaho 7th-10th June 1995.


Fowler J, Carson L, Twiggs L. Quality of life assessment in gynecologic cancer patients: a preliminary report. Gynecol Oncol 1995;58(3):412.

51. Carter JR. Lau M, Fowler J, Carlson J, Carson L, Twiggs L. Blood flow characteristics of ovarian tumors: Implications for ovarian cancer screening. Abstracted in ACOG Current Journal Review 1995;8(5):37.


L, Carson L. Invasive hemodynamic monitoring for the assessment and optimization of the cardiovascular status in patients undergoing gynecologic oncology surgery. Abstract 32. Gynecol Oncol

1995;56(1):109-144.


L, Carson L. Invasive hemodynamic monitoring for the assessment and optimization of the cardiovascular status in patients undergoing

Jonathan Carter, M.D., Page 32 gynecologic oncology surgery. Book of abstracts 26th Annual Meeting,

The Society of Gynecologic Oncologists 1995.


Carney P, Carson L, Twiggs L. Radical hysterectomy for early stage cervical cancer: lymph node status and patterns of recurrence. Book of abstracts 23rd Annual Meeting of The Western Association of

Gynecologic Oncologists. Coeur d'Alene, Idaho 7th-10th June 1995.


Carney P, Carson L, Twiggs L. Radical hysterectomy for early stage cervical cancer: lymph node status and patterns of recurrence. Gynecol

Oncol 1995;58(3):413.


Twiggs L, Carson L. Nonsurgical management strategies for the functional complications of ileocolonic continent urinary reservoirs. Abstract 70.

Gynecol Oncol 1995;56(1):109-144.


Twiggs L, Carson L. Nonsurgical management strategies for the functional complications of ileocolonic continent urinary reservoirs. Book of abstracts

26th Annual Meeting The Society of Gynecologic Oncologists 1995.

58. Saltzman A, Carter JR. Fowler J, Julian S, Carlson J, Hartenbach E,

Carson L, Twiggs L. The utility of preoperative screening colonoscopy in gynecologic oncology. Abstracted in ACOG Current Journal Review

1995;8(5):36.

59. Carney P, Johnson P, Chen M, Cosin J, Carter JR. Fowler J, Twiggs L,

Carson L. The effect of sartorius transposition on wound morbidity following inguinal-femoral lymphadenectomy. Abstract 190. Gynecol Oncol

1996;60(1):147.


Fowler J, Carson L, Twiggs L. Lack of adverse effect on quality of life of up to 6 cycles of chemotherapy in gynecologic cancer patients. Book of abstracts 27th Annual Meeting of the Society Gynecologic Oncologists

1996.

61. Carter JR. Fowler J, Carlson J, Carson L, Twiggs L. Just how accurate is the pelvic examination? A prospective comparative study. Abstracted in

Year Book of Emergency Medicine 1996;Mosby-Year Book Inc.

62. Carter JR. Johnson P, Saltzman A, Chen D, Carney P, Hartenbach E,

Fowler J, Carson L, Twiggs L. Lack of adverse effect on quality of life of up to six cycles of chemotherapy in gynecologic cancer patients. Abstract

47. Gynecol Oncol 1996;60(1):109.

63. Carter JR. Lau M, Fowler J, Carlson J, Carson L, Twiggs L. Blood flow characteristics of ovarian tumors: Implications for ovarian cancer screening. Abstracted in Year Book of Ultrasound 1996.

64. Carter JR. Lau M, Saltzman A, Hartenbach E, Chen M, Johnson P,

Fowler J, Carlson J, Carson L, Twiggs L. Gray scale and color flow characterization of uterine tumors. Abstracted in Year Book of Ultrasound

1996.


Fowler J, Carson L, Twiggs L. Lack of adverse effect on quality of life of up to 6 cycles of chemotherapy in gynecologic cancer patients. Book of

Abstracts. Annual Scientific Meeting, The Royal Australian College of

Obstetricians and Gynaecologists 1996.


66. Chen M, Carney P, Johnson P, Carter JR. Fowler J, Dusenbury K,

Mitchell S, Carson L, Potish R, Twiggs L. Phase I trial of weekly Taxol as a radiation sensitizer in advanced cervical cancer. Abstract 240. Gynecol

Oncol 1996;60(1):160.


Mitchell S, Carson L, Potish R, Twiggs L. Phase I trial of weekly taxol as a radiation sensitizer in advanced cervical cancer. Book of abstracts

Western Association of Gynecologic Oncologists, 24th Annual Meeting,

San Diego, California 29th May-1st June 1996.


Mitchell S, Carson L, Potish R, Twiggs L. Phase I trial of weekly taxol as a radiation sensitizer in advanced cervical cancer. Abstract. Gynecol Oncol

1996;62(3):418.


Carson L. A simplified method for detubularization in the construction of a continent ileocolic reservoir (Miami pouch). Book of abstracts Western


CA 29th May-1st June 1996.


Carson L. A simplified method for detubularization in the construction of a continent ileocolic reservoir (Miami pouch). Abstract 42. Gynecol Oncol

1996;62(3):425.

71. Gordon A, Bookman M, Malmstrom H, Bolis G, Mangioni C, Hall J, Carter

JR. Hudson I, Broom C. Efficacy of Topotecan in advanced epithelial ovarian cancer after failure of platinum and paclitaxel. International

Topotecan Study Group Trial. Abstract 763 Am Soc Clin Oncol, Vol 15

1996.

72. Mitchell S, Carson L, Twiggs L, Adcock L, Glubka B, Carney P, Chen M,

Fowler J, Carter JR. The evaluation of Procrit in the prevention of anemia in patients treated with Topotecan. ASCO Annual Meeting Philadelphia

PA 18th-21st May 1996.

73. Mitchell S, Carson L, Twiggs L, Adcock L, Glubka B, Carney P, Chen D,

Fowler J, Carter JR. The evaluation of Procrit in prevention of anemia in patients treated with Topotecan. Abstract 735 Am Soc Clin Oncol, Vol 15

1996.


Twiggs L. Total pelvic exenteration: the relationship between management of the pelvic floor and postoperative complications: the University of

Minnesota experience. Abstract 151. Gynecol Oncol 1996;60(1):137.

75. Saltzman A, Hartenbach E, Carter JR. Contreras D, Ramakrishnan S,

Twiggs L, Carson L. Transforming growth factor alpha levels in the serum and ascites of patients with advanced epithelial ovarian cancer. Abstract

154. Gynecol Oncol 1996;60(1):138.


Twiggs L. Total pelvic exenteration: the relationship between management of the pelvic floor and post-operative complications. Book of abstracts

Western Association of Gynecologic Oncologists, 24th Annual Meeting,

San Diego, CA 29th May-1st June 1996.


Twiggs L. Total pelvic exenteration: the relationship between management

Jonathan Carter, M.D., Page 34 of the pelvic floor and post-operative complications. Abstract 20. Gynecol

Oncol 1996;62(3):420.

78. Carter JR. Evaluation of the adnexal mass: implications for laparoscopic surgery. Book of abstracts VII Annual Scientific Meeting, Australian

Gynaecological Endoscopy Society Meeting. Sydney Australia 31st July 3-

2nd August 1997.

79. Carter JR. Evaluation of the adnexal mass: implications for laparoscopic surgery. Book of abstracts University of New South Wales and St. Luke's

Hospital Complex Practical Endoscopy Workshop. Sydney Australia 18th-

19th October 1997.


Mitchell S, Carson L, Twiggs L. Phase I trial of weekly Taxol as a radiation sensitizer in advanced cervical cancer. Abstract 73. Gynecol Oncol

1997;64(2):307.


Mitchell S, Carson L, Twiggs L. Phase I trial of weekly Taxol as a radiation sensitizer in advanced cervical cancer. Book of abstracts 28th Annual

Meeting of the Society Gynecologic Oncologists Abstract 19 1997.

82. Cooper M, Wong F, Carter JR. Initial experience of laparoscopic pelvic lymphadenectomy. Book of abstracts VII Annual Scientific Meeting,

Australian Gynaecological Endoscopy Society Meeting. Sydney Australia

31st July-2nd August 1997.

83. Carter JR. Gynaecologic tumour surveillance: possible role for transvaginal sonography. Book of abstracts 29th Annual Scientific

Meeting, Australian Society for Ultrasound in Medicine Adelaide

Convention Centre, Adelaide, South Australia 17th-19th September

1999:133-134.

84. Carter JR. MacGibbon A, Bucci J, Solomon H, MacLeod C. Whole abdominal radiotherapy following second look laparotomy for ovarian cancer. Abstract A9. Seventh Biennial Meeting of the International

Gynecologic Cancer Society. Int J Gynecol Cancer 1999;9((Supp 1)):3.

85. Inthasorn P, Beale P, Dalrymple C, Carter JR. Malignant mixed Mullerian tumor of the ovary: prognostic factor and response of adjuvant platinumbased chemotherapy. Abstract # OV 118. Int J Gynecol Cancer

2002;12(5):558.

86. Liu J, Thompson C, Huang X, Liao G, Rose B, Carter JR. The differences of human papillomavirus prevalence and clinicopathological features in cervical cancer between Chinese and Australian Women. Abstract # CV

027. Int J Gynecol Cancer 2002;12(5):585.

87. Beale P, Carter JR. Dalrymple C, Fazekas B, Zhou C, Childs A, Nattress

K. A Pilot study of dendritic cell immunotherapy in women with epithelial ovarian or primary peritoneal cancer. Poster presentation 10th Biennial

Meeting of the International Gynecologic Cancer Society. Edinburgh

Scotland 3rd-7th October 2004.

88. Culling B, Hamilton A, Andrews L, Nattress K, Carmalt H, Carter J . One year review of the Sydney Cancer Centre Breast and Ovarian Cancer Risk

Management Clinic. A combined meeting of kConFab, Australian Ovarian

Cancer Study (AOCS), ACCFS & Family Cancer Clinics of Australia and

New Zealand 2005;Couran Cove Island Resort. 30th August - 3rd

September, 2005.


89. Russell P, Dray M, Dalrymple C, Carter J . P16 immunostaining of colposcopically directed cervical biopsies. Book of Abstracts 20th Annual

Scientific Meeting Australian Society Gynaecologic Oncologists 2005.

90. Carter J , Sim J, Pather S, Dalrymple C, Land R, Abdel-Hadi M.

Recurrence after treatment for high grade cervical dysplasia. Book of

Abstracts 20th Annual Scientific Meeting Australian Society Gynaecologic

Oncologists 2005.

91. Carter J . Update on cancer of the uterus. Book of Abstracts. The XIXth

Asian-Oceanic Congress of Obstetrics and Gynecology 2005

92. Nattress K, Andrews L, Carter J , Culling B, Pather S, Hamilton A. An innovative multidisciplinary approach for the management of women at high risk of breast and ovarian cancer. Int J Gyn Cancer 2006;16(3):802.

93. Nattress K, Beale P, Carter J , Clark K, Dalrymple C, Waters A. The complex palliative care needs of women with epithelial ovarian cancer: a retrospective review. Int J Gyn Cancer 2006;16(3):801.

94. Murray B, Carter J , Coates A, Beith J. Benefit of endometrial biopsy (EB) in women randomized to tamoxifen or placebo for breast cancer prevention. Cancer Nurses Society of Australia. 2007;August 1-4(Abstract and oral presentation by 1st author).

95. Carter JR.


Society Annual Scientific Meeting Book of Abstracts. Kota Kinabalu,

Sabah Malaysia 16 th -19 th October 2009

96. Carter JR.


Annual Scientific Meeting Book of Abstracts. Kota Kinabalu, Sabah

Malaysia 16 th -19 th October 2009

97. Anderson C, Juraskova I, Harrison J, Beale P, Natress K, Philp S & Carter

J . When there is no evidence to guide: The development and pilot of a

Decision Aid to improve communication and decision making about treatment options for asymptomatic ovarian cancer patients with rising CA-

125. Poster presentation. COSA ASM, Sydney, 19 th November 2008.

98. Juraskova I, Harrison J, Nattress K, Anderson C, Lopez AL, Beale P,

Carter J . Rising CA125 in asymptomatic women: a clinical dilemma but what would women want to do? Accepted Abstract and poster 12 th

Biennial Meeting of the International Gynecologic Cancer Society Bangkok

Thailand 2008

99. Gainford MC, Tinker A, Carter J , Petru E, Nicklin J, Quinn M, Hammond I,

Elit L, Lenhard M, Friedlander M. Malignant transformation within ovarian dermoid cysts. An audit of treatment received and patient outcomes. A gynaecologic cancer intergroup (GCIG) study. University of Sydney,

Sydney NSW, Australia; BC Cancer Agency, Vancouver, BC, Canada;

Sydney Gynaecological Oncology Group, Sydney, Australia; University

Graz, Graz, Austria; Queensland Centre for Gynaecological Cancer,

Brisbane, Australia; Royal Womens Hospital, Melbourne, Australia; WA

Gynaecological Cancer Service, Perth, Australia; Juravinski Cancer

Centre, Hamilton, ON, Canada; Ludwig-Maximilians-University Munich,

Munich, Germany; Prince of Wales and Royal Womens Hospital, Sydney,

Australia. Abstract accepted e16533 ASCO 2009.

100. Anderson C, Juraskova I, Harrison J, Beale P, Nattress K, Philp S, Carter

J.

Where there is no evidence to guide: the development and pilot of a

Jonathan Carter, M.D., Page 36 decision aid to improve communication and decision making about treatment options for asymptomatic ovarian cancer patients with rising

CA125. Inaugural Joint Conference Australian New Zealand

Gynaecological Oncology Group and Austalian Society of Gynaecological

Oncologists. Noosa Sheraton Resort and Spa. 1-5 April 2009.

101. Juraskova I, Nattress K, Anderson C, Lubotzky F, Carter J.

The good, the bad and the dilator: information needs and acceptance of vaginal dilators following radiation for gynaecological cancer. Inaugural Joint Conference



1-5 April 2009.

102. Tai D, Atkinson K, Dalrymple K, Pather S, Philp S, Nattress K, Carter J.

A prospective study on patient satisfaction with the Oncology/Dysplasia

Service at the Sydney Cancer Centre. Inaugural Joint Conference



1-5 April 2009.


Fast track surgery in gynaecological oncology. A clinical audit. Inaugural

Joint Conference Australian New Zealand Gynaecological Oncology

Group and Austalian Society of Gynaecological Oncologists. Noosa

Sheraton Resort and Spa. 1-5 April 2009.

104. Nattress K, Carter J , Beale P, Philp S, Knight C, White K. Do current follow up practices meet the needs of gynaecological cancer survivors? cInaugural Joint Conference Australian New Zealand Gynaecological

Oncology Group and Austalian Society of Gynaecological Oncologists.

Noosa Sheraton Resort and Spa. 1-5 April 2009.

105. Ding Z, Jiang C, Pather S, Dalrymple C, Atkinson K, Murali R, Al-Rayyan

E, Luo K, Carter J . The outcome of cervical intraepithelial neoplasia 2 diagnosed by punch biopsy in 131 women. Book of Abstracts. 21 st

Australian Society for Colposcopy and Cervical Pathology (ASCCP)

Crowne Plaza Hotel Darwin Northern Territory 13-16 August 2009

106. Carter J, Philp S, Arora V , Smirnova S, Patel P, Nattress K, Pather S,

Dalrymple C, Cotterell S. Discharge on Postop Day 2 after Major

Gynaecological Surgery. Is it Possible? Book of Abstracts 25 th Annual

Scientific Meeting Australian Society of Gynaecological Oncologists.

Bunker Bay Western Australia 23-28 th March 2010

107. Philip S, Carter J , Pather S, White K. Fast track surgery and nurse led follow up in gynaecological oncology: a new model of care. Cancer Nurses

Society of Australia, 14th Winter Congress, Sydney. Convention and

Exhibition Centre, Sydney, 21 - 23 July 2011

108. Carter J , Philp S. Am I doing what I think I am doing? A clinical audit assessing outcomes after fast track surgical management of corpus cancer. Australian Society of Gynaecologic Oncologists 26 th Annual


2011

109. Rao A, Pather S, Philp S, Carter J.

A case controlled study comparing total laparoscopic hysterectomy and fast track open hysterectomy in a gynaecological oncology unit. Australian Society of Gynaecologic




110. Carter J , Philp S. Program development and extended experience with a fast track surgery program. Australian Society of Gynaecologic




J . Improving communication about recovery following pelvic radiation: A pilot of an information booklet for women with gynaecological or anorectal cancer. Asia-Pac J Clin Oncol 2011; 7 (Suppl. 4): 140.


J . Barriers and facilitators affecting dilator use after pelvic radiotherapy for gynaecological cancer: the patient perspective. Supportive Care in

Cancer, 19(S2):S330



The Development And Evaluation Of Two Decision Aids. Supportive Care in Cancer, 19(S2):S325



The Development And Evaluation Of Two Decision Aids. Supportive Care in Cancer, 19(S2):S325

115. F Lubotzky, I Juraskova, K Nattress, S Philp, S Carroll, C Milross & J

Carter.

Improving communication about recovery following pelvic radiation: A pilot of an information booklet for women with gynaecological or anorectal cancer. Asia-Pacific Journal of Clinical Oncology, 7(S4):282


J . Improving communication about recovery following pelvic radiation: A pilot of an information booklet for women with gynaecological or anorectal cancer. Asia-Pac J Clin Oncol 2011; 7 (Suppl. 4): 140.

117. F Lubotzky, I Juraskova, K Nattress, S Philp, C Milross, J Carter.



Cancer. Supportive Care in Cancer, 19(S2):S331

118. Philip S, Carter J , Pather S, White K. Fast track surgery and nurse led follow up in gynaecological oncology: a new model of care. Cancer Nurses

Society of Australia, 14th Winter Congress, Sydney. Convention and

Exhibition Centre, Sydney, 21 - 23 July 2011


J.

Barriers and facilitators affecting dilator use after pelvic radiotherapy for gynaecological cancer: the patient perspective. Supportive Care in

Cancer, 19(S2):S330

120. Lubotzky F, Juraskova I, Nattress K, Philp S, Milross C, Carter J .



Cancer. Supportive Care in Cancer, 19(S2):S331


Pather S. Enhancing fertility preservation in women with gynaecological cancer. Asia Pacific Journal of Clinical Oncology 2011; 7(S4): S140

122. Taylor J, Juraskova I, Lobb E, Dalrymple C, Carter J . Experiences Of

Women With Vulvar Intraepithelial Neoplasia (Vin): A Qualitative Insight.

Supportive Care in Cancer, 19(S2):S332


123. Al-Aker M, Pather S, Gibson S, Carter J . Preoperative use of Gabapentin as an adjuvant for postoperative analgesia in women undergoing

Laparotomy for treatment of malignant or suspected malignant gynaecologic diseasesd. ASGO 2013

124. Rao A, Carter J . Title: Venous thromboembolism (VTE) prophylaxis in patients undergoing surgery for gynaecological malignancy

– a survey of current practice of Certified Gynaecologic Oncologists (CGO’s) in

Australia and New Zealand. ASGO 2013.

125. Nagrial A, Chin V, Carter J, Beale P. Duration of systemic therapy for ovarian cancer: a systematic review and meta-analysis. Submitted ASCO

2014


Administrative Responsibilities:

2013

1. Carter J. RPAH Credentialing Committee

2. Carter J. Operating Theatre Management Committee Meeting.

3. Carter J. SCC Heads of Department

4. Carter J. RPAH Clinical Council

5. Carter J RPAH Heads of Department

6. Carter J. RPAH Medical Board (Medical Staff Council)

7. Carter J. Lifehouse Interventional User Group

8. Carter J. Lifehouse Ambulatory Care Gynae Clinic User Group

9. Carter J. Lifehouse Advisory Council

10. Carter J. SLHD Medical Staff Executive Council

11. Carter J. RPAH Theatre Procedures Committee

12. Carter J. Lifehouse Clinical Leadership Committee

13. Carter J. Lifehouse MDAC Committee

14. Scientific Advisory Panel T

he Australian Gynaecological Cancer

Foundation. 24

th

February 2014.


Grants

1. Carter JR . An open, multicenter randomised phase III study of Topotecan versus Taxol in women with advanced ovarian cancer and have failed a prior regimen of Cisplatin or Carboplatin. Principal Investigator. Smith

Kline Beecham 104864-A/039. $30,000 1993.

2. Carter JR . An open, multi-centre phase II study of intravenous Topotecan in advanced epithelial ovarian cancer in patients who have failed a prior regimen of Taxol and Cisplatin. Principal Investigator. SmithKline

Beecham 104864-A/033. $30,000 1995.

3. Carter JR.

Ultrasound and tumour marker characterization of ovarian tumours. Viertel Clinical Investigatorship. Sylvia & Charles Viertel

Charitable Foundation. Awarded $50,000. 1996.

4. Fazekas B, Millward M, Carter JR , (Associate Investigator), Beale P. A pilot study of tumour-RNA pulsed dendritic cell immunotherapy in ovarian cancer. NSW Cancer Council Project Grant. $146,814 2000-2001.

5. Bowtell, deFazio, Wyld, Whiteman, Gertig, Friedlander, Harnett,

Bloomfield, Davy, Zeps, Carter JR, (Associate Investigator). Molecular epidemiology of ovarian cancer: Australian Ovarian Cancer Study.

Protocol No XO2-0127. Protocol No XO2-0127. Council Multi-State

Research Grant 2002;Amount: 2003 $276,500; 2004 207,500; 2005

$69,500.

6. Carter JR.

Phase III randomised trial of paclitaxel and carboplatin verses triplet or sequential doublet combinations in patients with epithelial ovarian or primary peritoneal carcinoma. Co-Investigator. Protocol XO2-0070.

Gynecologic Oncology Group #0182 2002;Funding to ANZGOG.

7. Carter JR . Infrastructure Grant. The Sydney Cancer Centre Foundation.

$78,276 2003.

8. Carter JR.

Enhancement funding for data manager. Greater Metropolitan

Transition Task Force. $150,000 per year 2003. On-going funding.

9. Bequest from the estate of Edna May Skelton. $155,000 2004.

10. Carter JR.

A phase 2 study of oxaliplatin in combination with paclitaxel in patients with locally recurrent of metastatic cervical cancer. Co-

Investigator. Protocol XO3-0141- NCI #4840 2004;Funding to ANZGOG.

11. Carter JR.

A study of risk-reducing salpingo-oophorectomy and longitudinal CA125 screening among women at increased risk of ovarian cancer. Co-Investigator. Protocol XO4-0248. Gynecologic Oncology Group

Protocol No 0199 2004;Funding to ANZGOG.

12. Carter JR.

Infrastructure Grant. The Sydney Cancer Centre Foundation.

$20,000 2004.

13. Carter JR.


$5,000 2004.

14. Carter JR.

Intrastructure Grant. The Sydney Cancer Centre Foundation.

$1,800 2004.

15. Carter JR.


$850 2004.

16. Carter JR.


$20,000 2004.

17. Carter JR.


$20,000 2004.


18. Carter JR.


$20,000 2004.

19. Carter JR . Infrastructure Grant. Laparoscopic surgical trainer. The Sydney

Cancer Centre Foundation. $1780 2005.

20. Carter JR . Infrastructure Grant. Colposcope. The Sydney Cancer Centre

Foundation. $22,200 2005.

21. Sitas F, O'Connell D, Banks E, Frazer I, Carter J (Collaborator). The effect of exogenous hormones, smoking and HPV on the incidence of screen detected pre-invasive cervical cancer, Project Grant, $289680 in

2006; $247680 in 2007; $225430 in 2008; $225430 in 2009; $225430 in

2010. NHMRC 2005. $1,151,625 over 5 years 2005.

22. Carter J . Infrastructure Grant. Harmonic Scalpel. The Sydney Cancer

Foundation: $50,000. 2007.

23. Carter J , Juraskova I, Nattress K, Harrison J, Dalrymple C, Pather S,

Beale P. Improving communication and decision making about treatment options for asymptomatic ovarian cancer patients with rising CA125: The development of a decision aid. $50,000 The Sydney Cancer Centre

Foundation. 2007-8.

24. Sitas F, O'Connell D, Canfell K, Barton M, Ward R, Banks E, Boyer M,

Milross C, Carter J , Menzies S, Horvath L. The NSW Cancer, Lifestyle and Evaluation of Risk Study (CLEAR Study). 2007. $2.5Million over 5 years from 2006-2011

25. Nattress K, Beale P, Carter J

& White K ‘Impact of a nurse led wellness clinic on the physical and psychological sequelae of women who have been treated for gynaecological cancer’   . Clinical Research Grant Cancer

Institute NSW Nursing and Allied Health Clinical Research Grant, 2008

($80,000)

26. Nattress K, Carter JR . National Centre for Gynaecological Cancer/

Cancer Australia Development of an Interactive Training Module for

Health Professionals to Address the Psychosexual Care of Women

Affected by Gynaecological Cancers – Member of Project Team 2009

($341,000)

27. Carter JR , Philp S. To co-ordinate and evaluate a Fast Track Surgery

Enhanced recovery and advanced nurse supported discharge program for gynaecological oncology patients. Lifehouse at RPA, the New Sydney

Cancer Centre Capital Works and Equipment Grants, April 2009. $81,986

28. Carter JR. Protocol Review for SSWAHS Ethics Review Committee.

Protocol No X10-0202 & HREC/10/RPAH/355

– “Mo22224: A multicentre, open-label, randomized, two arm Phase III trial of bevacizumab plus chemotherapy versus chemotherapy alone in patients with platinum resistant epithelial, fallopian tube or peritoneal cancer (AURELIA)”. 16 th

July 2010

29. Schofield P, Aranda S, Juraskova I, Mileshkin L, Krishnasamy M, White K,

Carter J (Assoc/Clinical Investigator) et al. PeNTAGOn: Peer and Nurse support Trial to Assist women in Gynaecological Oncology. A nurse led psychosocial intervention with peer support to reduce needs in women being treated with radiotherapy for gynaecological cancer: A RCT.

NHMRC Project Grant:1005708. $1,133,411.80 (2011-2014)

30. Butow P (CI), Carter J (CI), Associate Investigators: Juraskova I, Lopez

AL, Philp S, Hobbs K, Gard G, Turner J, Phillips E, Robertson R, Nattress

K, Costa D, Wilkinson C, Burrell K. Assessing unmet needs in women with

Jonathan Carter, M.D., Page 42 gynaecological cancers; The first step. Cancer Institute NSW. Research

Innovation Grant. 10/RFG/2-35 $48,679. Jan 2011-Dec 2011

Awards & Honours

1. Carter JR. Commonwealth Scholarship. 1973-1975.

2. Carter JR. A comparative study of benign and malignant tumors using transvaginal color flow Doppler. Virginia K. Pierce Award The Society of

Memorial Gynecologic Oncologists Fifteenth Annual Meeting. Presidents

Award for best presentation. Dearborn Michigan 7th-10th October 1992.

3. Carter JR. Flow characteristics in benign and malignant gynecologic tumors using transvaginal color flow Doppler. Selected by Program

Committee to be highlighted to the media 25th Anniversary Meeting, The

Society of Gynecologic Oncologists, Orlando, Florida 6th-9th February

1994.

4. Carter JR. Lack of adverse effect on quality of life of up to 6 cycles of chemotherapy in gynecologic cancer patients. Young Investigator Award

The Royal Australian College of Obstetricians and Gynaecologists 1996

Annual Scientific Meeting Nadi Fiji 30th June-5th July 1996.

5. Carter JR. Ultrasound and tumour marker characterization of ovarian tumours. Viertel Clinical Investigatorship. Sylvia & Charles Viertel

Charitable Foundation. Awarded $50,000. 1996.

6. Carter JR. Turnbull Scholar University of Melbourne and The Royal

Women's Hospital. 1997.

7. Carter JR. Certificate of Appreciation The University of Sydney Faculty of

Medicine. Recognition of the contribution made to the Postgraduate

Committee in Medicine 2001.

8. Carter JR.

Debate Winner. TLHBSO (without lymphadenectomy) should be the standard management for women with clinical stage I endometrial cancer. Australian Society of Gynaecologic Oncologists 26 th Annual


2011

9. Carter JR.

Finalist 2011 Premier’s Awards for research Fast track and enhanced recovery after surgery for gynaecological cancer. 7 th November

2011

10. Carter J . Certificate of Appreciation Cancer Council New South Wales for contribution to booklet Understanding Vulva and Vaginal Cancers.

November 2011

11. Carter J.

Awarded on behalf of the Sydney Gynaecological Oncology

Group was awarded First Place in the Sydney Local Health District 2011

Quality Awards in the category Improving access to timely quality healthcare: Fast track surgery: better outcomes for patients. 6 th December

2011

12. Carter J.


Group was awarded The Sydney Local Health District Board Award for

Innovation in Healthcare in our Hospitals and Services. Program of Fast

Track and Enhanced Recovery after surgery for women with gynaecological cancer. 6 th December 2011

13. Carter J.


Group, The Sydney Local Health District Board 2013 Quality Award in the category “Integrated Health Care” for Fast Track Surgery Program for

Gynaecological Cancer. 5 th December 2013


14. Carter J.

Article “A 5-Year review of gynaecological oncology patients managed by a fast track surgery program” chosen and promoted on

Scientific Research Publishing newsletter. http://image.ljemail.org/archive/nl20140117en.htm?utm_campaign=nl2014

0117en

Investigatorship and Ethics Submissions 2014

1. Anderson L, O’Toole S, Beale P, Carter J. BRAF and KRAS oncogene mutation testing in low grade serous adenocarcinoma and serous borderline ovarian tumours using Sequenom OncoCarta Panel.

2. Hoffmann, Oehler, Koch, Ruszkiewicz (CI), Carter J (AI). Project Grant 2015.

Application ID:1086933. Defining a molecular signature of metastasis in gynaecological cancer. NHMRC 2014

Memberships in Professional Organizations (Current and Past)

1. Royal Australian College Obstetricians and Gynaecologists. 1988-2014

2. American Institute of Ultrasound in Medicine. 1991.

3. Western Association Gynecologic Oncologists. 1993.

4. International Society Study of Vulvar Disease. 1993.

5. Fellow American College of Angiology. 1993.

6. Hennepin County Medical Society. 1993.

7. Australian Medical Association. 1994-2014.

8. American Society of Clinical Oncology. 1994.

9. Australian Society Gynaecological Oncologists. 1996-2014.

10. Australasian Society for Ultrasound in Medicine. 1996.

11. American College of Surgeons. 1997-2014.

12. International Society of Gynecologic Cancer. 1997-2014.

13. Society of Gynecologic Oncologists. Member. 1999-2014.

14. University of Sydney Association of Professors. 2013-2014

Referee in Peer Review Journal (Current and Past)

1. Obstetrics and Gynecology

2. Gynecologic Oncology

3. Cancer. January

4. Ultrasound in Obstetrics and Gynecology

5. International Journal Gynecologic Cancer

6. American Journal Obstetrics and Gynecology

7. Australian & New Zealand Journal Obstetrics and Gynaecology

8. Medical Journal of Australia. 2002 – present

9. The Lancet

10. Oncology.

11. Asia-Pacific Journal of Clinical Oncology

12. Open Journal of Obstetrics and Gynecology

13. Medicine Today

14. Expert Review of Anticancer Therapy

15. Medial Journal of Australia (2014)

16. International Journal of Gynecology and Obstetrics (2014)

17. Acta Obstetricia et Gynecologica Scandinavica (2014)


Editorial Committee

1. Carter J. Board Member The Open Women ’s Health Journal. 17 th May 2013

2. Carter J.

Editorial Board Member Austin Journal of Obstetrics and

Gynecology. 1 st February 2014

Course Organization or Instruction

1. Carter JR. Course Instructor. Continent Urinary Diversion Course.

University of Minnesota. 12th-13th May 1991.

2. Carter JR. Course Convener and Instructor. An Instruction Workshop in

Transvaginal Ultrasound. University of Minnesota. 14th December 1991.

3. Carter JR. Course Convener. Update Gynaecology Symposium. The

Postgraduate Committee in Medicine at The University of Sydney. 26th

October 1996.

4. Carter JR. Course Faculty. The Sydney Gynaecological Endoscopy

Group Symposium. Liverpool Hospital, Sydney. 4th November 1996.

5. Carter JR. Course Faculty and Instructor. Post-Valedictory Symposium

Workshop on Advanced Gynaecological Laparoscopy, Hysteroscopy &

Falloposcopy. National University of Singapore. 18th-21st November

1996.

6. Carter JR. Course Faculty. The Sydney Gynaecological Endoscopy

Group Symposium at Liverpool Hospital, Sydney. 24th-25th February

1997.


Postgraduate Committee in Medicine at The University of Sydney. August

1997.


Postgraduate Committee in Medicine at The University of Sydney. 5th

September 1998.

9. Carter JR. Course Convener. Advances and Controversies in Pelvic

Surgery. The Postgraduate Committee in Medicine at The University of

Sydney and The Pelvic Surgery Unit, King George V Hospital. 17th-18th

October 1998.

10. Carter JR. Course Convener. Royal Prince Alfred Hospital Medical

Officers Reunion Week and McIllwrath Professor. 19th-23rd October

1998.

11. Carter JR. Course Convener. Update in Gynaecology Symposium.

Postgraduate Committee in Medicine. The University of Sydney. 11th

September 1999.

12. Carter JR. . Course Convener. Women's Health Update. Postgraduate

Committee in Medicine. The University of Sydney. 1st April 2000.

13. Carter JR. Course Convener. Women's Health Update. Postgraduate

Committee in Medicine. The University of Sydney. 5th August 2000.

14. Carter JR. Course Convenor. Advances and Controversies in

Gynaecology and Pelvic Surgery II. The University of Sydney. 2000:7th-

8th October.

15. Carter JR.

Course Instructor. Gross Topographical Regional Anatomy of the Female Abdomen, Pelvis and Perineum by Dissection with

Application. Department of Anatomy and Histology. The University of

Sydney 2005.


16. Carter JR. Course Convenor. Advances in Gynaecologic Oncology.

Presented by the Sydney Cancer Centre and the Sydney Gynaecologic

Oncology Group. 10th November 2004.

17. Carter JR . Course Instructor. Gross Topographical Regional Anatomy of the Female Abdomen, Pelvis and Perineum by Dissection with


Sydney 2005.

18. Carter JR.

Course Convenor. 2nd Annual Advances in Gynaecological

Oncology. The Sydney Gynaecological Oncology Group, The Sydney

Cancer Centre and Royal Prince Alfred Hospital 2005;9th November

2005.

19. Carter JR.

Course convenor Future Directions in Cancer Care. 10th

Anniversary Symposium Sydney Cancer Centre 3rd November 2006.

20. Carter JR.

Course convenor 3rd Annual Advances in Gynaecological

Oncology. Sydney Gynaecological Oncology Group 2nd November 2006.

21. Carter JR . Course Instructor Gross Topographical Regional Anatomy by

Dissection with application for obstetric and gynaecological trainees. The

University of Sydney Discipline of Anatomy and Histology. 26-28 October

2007.

22. Carter JR.

Program Committee Inaugural Joint Conference Australia New

Zealand Gynaecological Oncology Group and Australian Society of

Gynaecologic Oncologists. Noosa QLD. April 2009

23. Carter J, Philp S, TejadaBerges T, Young C. Course Convenor. 10 th

Annual Advances in Gynaecological Oncology. 4 th April 2014

Grand Rounds Presentations

1. Carter JR. Proliferating and invasive epithelial ovarian tumors in young women. Grand Rounds presentation St. Joseph's Hospital, St Paul, MN

10th August 1990.

2. Carter JR. Carcinoma of the endometrium. Grand Rounds presentation

Ramsey Medical Center, St. Paul, Minnesota 12th December 1990.

3. Carter JR. Screening for ovarian cancer: newer techniques. Grand

Rounds presentation St. Cloud Hospital, St. Cloud, Minnesota 10th May

1991.

4. Carter JR. Transvaginal ultrasound for the gynecologist. Grand Rounds presentation Department of Obstetrics and Gynecology, University of

Cincinnati College of Medicine Cincinnati, Ohio 22nd September 1991.

5. Carter JR. Current trends in transvaginal ultrasound, including ovarian cancer screening. Grand Rounds presentation Department of Obstetrics and Gynecology, University of Cincinnati College of Medicine Cincinnati,

Ohio 22nd September 1991.

6. Carter JR. Ovarian cancer screening. Grand Rounds presentation

University of Hawaii, Kapiolani Medical Center 19th February 1993.

7. Carter JR. Transvaginal sonography for the gynecologist. Grand Rounds presentation University of Minnesota Medical School, Department of

Obstetrics and Gynecology 16th January 1993.

8. Carter JR. Treatment of gynecologic malignancy and the role of the pathologist. Invited lecture. Grand Rounds presentation University of

Minnesota Medical School, Department of Laboratory Medicine and

Pathology, Division of Surgical Pathology. October 11, 1995.



Obstetrics and Gynecology. 25th February 1995.

10. Carter JR. An update on gynaecologic oncology. Grand Rounds presentation Woden Valley Hospital, Canberra, ACT 5th February 1996.

11. Carter JR. Cervical Cancer Screening into the 21st Century. Grand

Rounds presentation Sydney Cancer Centre Royal Prince Alfred Hospital

26th July 2004.

12. Carter JR . Ovarian Cancer: Advances and Controversies. Grand Rounds

Presentations, Sydney Cancer Centre. 2007;1st May, 2007.


Teaching, Medical Student & University Activities

1. Carter J.

Lecture: Evaluation of the Adnexal Mass. 25 th March 2011

2. Carter J.

Lecture: Evaluation of the Adnexal Mass. 29 th July 2011

3. Carter J.

Lecture: Evaluation of the Adnexal Mass. 14 th October 2011

4. Carter J.

Lecture: Cervical Cancer Screening, Diagnosis and

Management. 17 th October 2011

5. Carter J.

Lecture: Management of Cervical Cancer. 17 th October 2011

6. Carter J.

SCORPIO: HPV and Vaccination. 17 th October 2011.

7. Carter J.

Lecture: Evaluation of the Adnexal Mass. 23 rd March 2012.

8. Carter J.

Lecture: Evaluation of the Adnexal Mass. 25 th May 2012

9. Carter J.


10. Carter J.

Lecture: Evaluation and Management of the Abnormal Pap smear. 22 nd October 2012

11. Carter J.

Lecture: Management of Cervical Cancer. 22 nd October 2012

12. Carter J.

SCORPIO: HPV and Vaccination. 22 nd October 2012

13. Carter J.

Lecture: Evaluation of the Adnexal Mass. 22 nd March 2013

14. Carter J.


15. Carter J.

Level D Clinical Academic Titles Committee.

Dr Edith Weisberg

16. Carter J.

Lecture: Evaluation of the Adnexal Mass. 11 th October 2013

17. Carter J.

SCORPIO: HPV and Vaccination. 21 st October 2013

18. Carter J.

Registration as Auxillary Supervisor (Associate Supervisor) of

Higher Degree Research Candidates at Sydney Medical School. 26 th

February 2014.

Media

1. Carter J. Interview Modern Medicine. Long term outcomes for women treated for cervical precancer. 22 nd Jan 2014


Invited Lectureships, Guest or Program Chair

1. Carter JR. Transvaginal ultrasound for the gynecologist. Invited speaker


College of Medicine. Current trends in transvaginal ultrasound, including ovarian cancer screening, sponsored by ADR Ultrasound. Cincinnati, Ohio

22nd September 1991.

2. Carter JR. Current trends in transvaginal ultrasound, including ovarian cancer screening. Invited speaker Department of Obstetrics and

Gynecology, University of Cincinnati College of Medicine, sponsored by

ADR Ultrasound. Cincinnati, Ohio 22nd September 1991.



4. Carter JR. Ovarian cancer screening.,. Grand Rounds presentation


5. Carter JR. Transvaginal sonography for the gynecologist. Invited lecture.

Grand Rounds presentation University of Minnesota Medical School,

Department of Obstetrics and Gynecology. 25th February 25 1995.

6. Carter JR. Color Doppler sonography in gynecologic oncology. Invited speaker 19th Annual Sonography Symposium Vanderbilt University

School of Medicine, Nashville, Tennessee 25th May 1995.

7. Carter JR. Treatment of gynecologic malignancy and the role of the pathologist. Invited lecture. Grand Rounds presentation University of

Minnesota Medical School, Department of Laboratory Medicine and

Pathology, Division of Surgical Pathology. October 11, 1995.

8. Carter JR. Update on Gynaecological Cancers. Presentation 66th

General Revision Course, Postgraduate Committee in Medicine, The

University of Sydney 15th July, 1996.

9. Carter JR. Colour Flow Doppler in Gynaecologic Oncology. Presented at the 3rd National Conference of The Australian Sonographers Association.

Sydney 20-21 July 1996.

10. Carter JR. Laparoscopic pelvic lymphadenectomy. Presented at the Post-

Valedictory Symposium Workshop on Advanced Gynaecological

Laparoscopy, Hysteroscopy & Falloposcopy. National University of

Singapore. 18th-21st November 1996.

11. Carter JR. Ovarian cancer screening versus early detection. An update.

Presented as The Turnbull Scholar, The University of Melbourne and The

Royal Women's Hospital, Victoria 19th-23rd May 1997.

12. Carter JR. Transvaginal sonography for the gynaecologist. Presented as

The Turnbull Scholar, The University of Melbourne and The Royal

Women's Hospital, Victoria. 19th-23rd May 1997.

13. Carter JR. An update on gynaecologic oncology. Presented as The

Turnbull Scholar, The University of Melbourne and The Royal Women's

Hospital, Victoria. 19th-23rd May 1997.

14. Carter JR. Evaluation of the adnexal mass: implications for laparoscopic surgery. Invited speaker VII Annual Scientific Meeting, Australian

Gynaecological Endoscopy Society Meeting. Sydney Australia. 31st July-

2nd August 1997.

15. Carter JR. Ovarian cancer screening-the gynaecologic oncologists perspective. Invited speaker Annual Scientific Meeting, Australian


Association of Obstetric and Gynaecologic Ultrasonographers Meeting,

Queenstown, New Zealand 20th-23rd August 1998.

16. Carter JR. What is the appropriate clinical approach to screening for cervical cancer? Does ultrasound have a role? Invited speaker Annual

Scientific Meeting, Australian Association of Obstetric and Gynaecologic

Ultrasonographers Meeting, Queenstown, New Zealand. 20-23rd August

1998.

17. Carter JR. The clinicians approach to the diagnosis of uterine neoplasia.

Is ultrasound reliable? Invited speaker Annual Scientific Meeting,

Australian Association of Obstetric and Gynaecologic Ultrasonographers

Meeting, Queenstown, New Zealand 20th-23rd August 1998.

18. Carter JR. Laparoscopy in gynaecologic oncology: we can but should we?

Presentation 9th Annual Scientific Meeting of the Newcastle Obstetrical and Gynaecological Society. John Hunter Hospital 18th September 1998.

19. Carter JR. Pelvic Surgery: Advances and Controversies. Program Chair

Postgraduate Committee in Medicine, The University of Sydney & Pelvic

Surgery Unit, King George V Hospital. Menzies Hotel, Sydney Australia


20. Carter JR. Gynaecologic Oncology Group Meeting. Program Chair

Clinical Oncology Society of Australia (COSA) 25th Annual Scientific

Meeting, Sydney Australia 26th November 1998.

21. Carter JR. Ovarian Cancer. Program Chair Update on Gynaecological

Oncology, Session 4, Royal Hospital for Women, Randwick 30th April-1st

May 1999.

22. Carter JR. An experience with transvaginal sonography in gynaecological tumour detection. Invited speaker University of Minnesota Division of

Gynecologic Oncology Consensus Conference. Minneapolis Minnesota

16th October 1999.

23. Carter JR. Women's Health Update for General Practitioners. Program

Chair Postgraduate Committee in Medicine, The University of Sydney 5th

August 2000.

24. Carter JR. Evaluation of Pelvic Mass. Invited speaker Western

Metropolitan Obstetric & Gynaecological Society Liverpool Hospital 20th

August 2000.

25. Carter JR. Approaches to the management of corpus cancer.

Presentation Advances and Controversies in Gynaecology and Pelvic

Surgery II. The University of Sydney 7th-8th October 2000.

26. Carter JR. Ovarian cancer treatment in Australia. Invited speaker The

University of Minnesota Women's Cancer Centre. Minneapolis, MN 4th

March 2001.

27. Carter JR. Laparoscopy in gynaecological oncology, we can but should we. Invited speaker 1st Guangzhou International Symposium on

Oncology. Guangzhou China 28th-30th April 2002.

28. Carter JR. How to follow up treated patients. Invited speaker Meet the

Professor Series. 9th Biennial Meeting of the International Gynecologic

Cancer Society. Seoul, Korea. 20th-24th October 2002.

29. Carter JR. External Examiner (Conjoint appointment with Universiti of

Malaya, Universiti Sains Malaysia and University Kebangsaan Malaysia.

Master of Obstetrics and Gynaecology Examinations (Part II) Kuala

Lumpur, Malaysia 16th-19th May 2004.




26th July 2004.

31. Carter JR.

Course Instructor. Gross Topographical Regional Anatomy of the Female Abdomen, Pelvis and Perineum by Dissection with


Sydney August 19-21, 2005.

32. Carter JR.

Gynaecological cancer: incidence and mortality. Approaching the care of patients with advanced or recurrennt gynaecoloigcal cancer

2006;Sydney Institute of Palliative Medicine(7th-8th April).

33. Carter JR . Presentation Australian Senate Community Affairs References

Committee Inquiry into Gynaecological Cancer in Australia. Public Hearing

2006;Parliament House, Macquarie St Sydney.

34. Carter JR . Hypothetical issues for debate-what are the obstacles to the uptake of laparoscopic surgery in gynaecological oncology? Invited

Faculty. The Limits of Endoscopic Surgery. An AGES Meeting in association with APAGE 2006;The Westin Hotel, Sydney. 18 th August

2006

35. Carter JR . Invited Speaker, 12th Annual Sydney General Practice

Continuing Education (GPCE) Forum. Ovarian cancer: advances and controversies. 2007 18-20 May; Sydney Showground Sydney Olympic

Park.

36. Carter JR.

Invited Reviewer Clinical Update Ovarian Cancer for the

National Breast Cancer Centre Ovarian Cancer Program. 2007 June(3).

37. Carter JR.

Surgical management of placenta accreta. Invited speaker

RANZCOG Combined NSW/QLD Annual Scientific Meeting: Emergencies and Complications in Obstetrics and Gynaecology. 2007 9-10th June;

Sheraton Four Points Hotel, Darling Harbour.

38. Carter JR.

Commentary. The diagnostic value of PET/CT for primary ovarian cancer. Ovarian Cancer Program Clinical Update Vol 3. 2007

June 2007;www.ovariancancerprogram.org.au.

39. Carter JR.

Ovarian cancer: advances and controversies. Invited speaker

King Hussein Cancer Centre, Amman Jordan 30-31 st August 2007

40. Carter JR.

Cervical cancer screening and management of the abnormal pap smear. Invited speaker King Hussein Cancer Centre, Amman Jordan

30-31 st August 2007

41. Carter JR.

Endometrial cancer update. Invited speaker King Hussein

Cancer Centre, Amman Jordan 30-31 st August 2007

42. Carter JR.


Society Annual Scientific Meeting. Kota Kinabalu, Sabah Malaysia 16 th -

19 th October 2008

43. Carter JR.


Annual Scientific Meeting. Kota Kinabalu, Sabah Malaysia 16 th -19 th

October 2008

44. Carter JR. Diagnosis and Staging Gynaecological Cancer at

Gynaecological Oncology Nursing Course, Professional Development and

International Relations, Faculty of Nursing and Midwifery, University of

Sydney 11 th February 2008


45. Carter JR. Diagnosis and Staging Gynaecological Cancer at

Gynaecological Oncology Nursing Course, Professional Development and

International Relations, Faculty of Nursing and Midwifery, University of

Sydney 17 th November 2008

46. Carter JR.

Prognosis in advanced and recurrent gynaecological cancer.

5 th Annual Advances in Gynaecologic Oncology. Sydney Gynaecological

Oncology Group Meeting. 21 st November 2008

47. Carter JR.

HPV in sexually active women-vaccinate or smear? Sydney

Annual Ho rmone & Women’s Health Update & Education Day. Clancy

Auditorium, UNSW Kensington. Saturday 21 February 2009.

48. Carter JR.

Ovarian and other pelvic cancers-update and overview.

Sydney Annual Hormone & Women’s Health Update & Education Day.

Clancy Auditorium, UNSW Kensington. Saturday 21 February 2009.

49. Carter JR.

Neoplastic changes in the endometrium. RANZCOG

NSW/ACT Registrar Training Day. Royal Hospital for Women. 27 th

February 2009.

50. Carter JR.

Session Chair at the Inaugural Joint Conference of ASGO and

ANZGOG. Noosa Sheraton Resort and Spa. 1-5 April 2009

51. Carter JR.

Invited Speaker AAGL 3 rd International Congress on Minimally

Invasive Surgery in conjunction with Australian Gynaecological Endoscopy

Society XIX Annual Scientific Meeting. Sex, Surgery and Gynaecology.

Gynaecological cancer management outside the big centre. 21-23 May

2009. Brisbane Australia

52. Carter JR.

HPV Update. Sheraton on the Park. 16 th July 2009

53. Carter JR.

Human Papilloma Virus Vaccination in Adult Women-Current

Trends and Thinking?. The Holme Building, Science Rd, University of

Sydney. 30 th July 2009

54. Carter JR.

Chair 6 th Annual Advances in Gynaecological Oncology. A

Tribute to Malcolm Coppleson. Kerry Packer Auditorium Royal Prince

Alfred Hospital. 20 th November 2009.

55. Carter JR. Invited speaker at lunch hosted by Jillian Skinner MP, Deputy

Leader of NSW Opposition, Shadow Minister for Health. Stranger’s Dining

Room, Parliament House Macquarie St Sydney. 5 th March 2010

56. Carter JR.

Invited speaker ASGO 2010 25 th Annual Scientific Meeting.

Bunker Bay Western Australia. Do we really need a CGO Examination?

23 rd -28 th March 2010

57. Carter JR.

Session Chair. ASGO 2010 25 th Annual Scientific Meeting.

Bunker Bay Western Australia. Follow up of Gynae Cancers. 23 rd -28 th

March 2010

58. Carter JR.

Invited speaker at Tina Robinson Memorial Dinner representing Lifehouse at RPA. Miramare Gardens. Terrey Hills 7 th August

2010

59. Carter JR.

Co-

Chair: Symposium 4: “Bench to Bedside”. RPAH Medical

Officers Association 76 th Annual “Reunion Week” Clinical Symposia.

Wednesday 8 th September 2010

60. Carter JR.

Invited Speaker. Ovarian cancer, past, present and future. 9th

Annual Women's Health Conference for General Practitioners.

16th October 2010 at the University of New South Wales, Barker St,

Randwick. 16 th October 2010


61. Carter JR. Invited speaker at lunch hosted by Jillian Skinner MP, Deputy

Leader of NSW Opposition, Shadow Minister for Health. Stranger’s Dining

Room, Parliament House Macquarie St Sydney. 4 th March 2011

62. Carter JR.

Debate Invitation. TLHBSO (without lymphadenectomy) should be the standard management for women with clinical stage I endometrial cancer. Australian Society of Gynaecologic Oncologists 26 th Annual


2011

63. Carter JR.

Session Chair Cervical Cancer Symposium. 2011 Clinical

Reunion Week. RPAH Medical Officers Association. 77 th Annual Reunion

Week Clinical Symposium. 25 th August 2011.

64. Carter JR.

Invited Lecture: HPV and Cervical Disease for the Clinician.

2011 Clinical Reunion Week. RPAH Medical Officers Association. 77 th

Annual Reunion Week Clinical Symposium. 25 th August 2011.

65. Carter JR.

Invited Speaker. Recent developments in the diagnosis and management of epithelial ovarian cancer. Australian Association of

Clinical Biochemists 49 th Annual Scientific Conference. Sydney

Convention Centre, Sydney 10 th -13 th October 2011.

66. Carter JR.

Invited Speaker. HPV Infection and Cervical Disease. 10 th

Annual Women’s Health Conference for General Practitioners. Univeristy of NSW, Randwick. 15 th October 2011

67. Carter J.

Session Chair 8 th Annual Advances in Gynaecological Oncology.

Kerry Packer Auditorium Royal Prince Alfred Hospital. 28 th November

2011

68. Carter J . ACHS Equip Periodic Review presentation. Development and extended experience with a fast track surgery program. Royal Prince

Alfred Hospital 12 th December 2011.

69. Carter J.

Invited Speaker AGES XXII Annual Scientific Meeting 2012 in association with the APAGE Regional Meeting. Risk reducing strategies for hereditary and high risk ovarian cancer. Hilton Hotel Sydney Australia

1 st June 2012

70. Carter J.


Society of Obstetricians and Gynaecologists. Risk reducing strategies for hereditary and high risk ovarian cancer. Le Royal Hotel Amman Jordan

26 th -29 th September 2012

71. Carter J.


Society of Obstetricians and Gynaecologists. An overview of cancer of the uterine corpus. Le Royal Hotel Amman Jordan 26 th -29 th September 2012

72. Carter J.


Society of Obstetricians and Gynaecologists. Cervical cancer screening and management of the abnormal pap smear. Le Royal Hotel Amman

Jordan 26 th -29 th September 2012

73. Carter J.

Session Chair. 9 th Annual Advances in Gynaecological

Oncology. The Sydney Gynaecological Oncology Group. Royal Prince

Alfred Hospital. 19 th October 2012

74. Carter J.

Invited speaker Inner West Sydney Medicare Local

Gynaecology Symposium. Cervical disease, HPV and management of the abnormal pap smear. 12 th June 2013

75. Carter J.

Invited Session Chair. 23 rd World Congress on Ultrasound in

Obstetrics and Gynecology. Sydney. 6 th -9 th October 2013


76. Carter J.

Invited Speaker. NSW Health Innovation Symposium 2013.

Stream 3: Integrated Health Care: Improving Outcomes after Major

Gynecologic Surgery. Sydney 11 th October 2013

77. Carter J.

Invited Speaker. An Update in Women’s Health. Enhanced recovery after surgery: standard of care. Bayer Healthcare. Sydney. 23 rd

October 2013

78. Carter J.

Invited Speaker. Postgraduate Seminar Hong Kong College of

Obstetricians & Gynaecologists. Optimising Recovery After Surgery. Hong

Kong. 9 th March 2014

79. Carter J.

Invited Speaker. Postgraduate Seminar Hong Kong College of

Obstetricians & Gynaecologists. An Overview of Apparent Early

Endometrial Cancer. Hong Kong. 9 th March 2014

80. Carter J.

Invited Speaker. University of Hong Kong. Department of

Obstetrics and Gynaecology. An Overview of Apparent Early Endometrial

Cancer. Hong Kong. 12 th March 2014

81. Carter J. Program Chair. 10 th Annual Advances in Gynaecological

Oncology. 4 th April 2014

82.


Local and Regional Abstracts and Presentations

1. Carter JR. The vacuum extractor-A review of the history, indications, contraindications, mechanics of use, maternal complications and fetal complications. Submitted for case commentary for M.R.A.C.O.G Part 2

1988.

2. Carter JR. Proliferating epithelial ovarian tumours in women under forty years: A retrospective review of King George V Hospital Gynaecological

Oncology Unit. Submitted for case commentary for M.R.A.C.O.G. Part 2

1988.

3. Carter JR. Women's Cancer Center protocols of management (a compilation of GOG and intramural protocols). 1st November 1990.

4. Carter JR. Proliferating and invasive epithelial ovarian tumors in young women. Presentation. Gynecologic Oncology Fellowship Didactic Series,

University of Minnesota Medical School 10th August 1990.

5. Carter JR. Proliferating and invasive epithelial ovarian tumors in young women. Presentation St. Joseph's Hospital, St Paul, MN 10th August

1990.

6. Carter JR. Carcinoma of the endometrium. Presentation Ramsey Medical

Center, St. Paul, Minnesota 12th December 1990.

7. Carter JR. For women only: A discussion on cancer screening.

Presentation University of Minnesota Hospital and Clinic Community

Services Department 14th January 1991.

8. Carter JR. Cancer screening. Presentation Rural Physician Associate

Program (RPAP), Olivia, Minnesota 29th January 1991.

9. Carter JR. An introduction to vaginal sonography. Presentation University of Minnesota Medical School 1st February 1991.

10. Carter JR. Cancer screening. Talk-back radio program on cancer screening in women, WCCO Radio, Minneapolis, MN 4th February 1991.

11. Carter JR. Profiles in survival. Presentation American Cancer Society. A two hour profile about cancer survivors, education and research featuring transvaginal sonography and color flow Doppler for early diagnosis of ovarian cancer. Channel 5 TV, Minneapolis Minnesota 6th April 1991.

12. Carter JR. The abnormal Pap smear. Presentation Family Practice

Review - Update. Minneapolis Minnesota 22nd-26th April 1991.

13. Carter JR. An overview of ovarian cancer. Presentation Department of

Surgery, Division of Surgical Intensive Care, University of Minnesota

1991:9th May.

14. Carter JR. Screening for ovarian cancer: newer techniques. Presentation

Grand Rounds. St. Cloud Hospital, St. Cloud, Minnesota 10th May 1991.

15. Carter JR. Transvaginal ultrasound in ovarian cancer screening.

Presentation Eighth Annual Symposium on Gynecologic Oncology,

University of Minnesota 14th May 1991.

16. Carter JR. Ovarian cancer screening. Presentation Women's Cancer

Center Staff, University of Minnesota 15th May 1991.

17. Carter JR. Ovarian cancer screening. Presentation Interdisciplinary

Cancer Conference, University of Minnesota 16th May 1991.

18. Carter JR. Unusual presentations of genital tract tuberculosis.

Presentation University of Minnesota Department of Obstetrics and

Gynecology Resident Graduation Scientific Day 28th June 1991.


19. Carter JR. Ovarian cancer screening using transvaginal sonography.

Presentation 22nd Annual Autumn Seminar: Obstetrics and Gynecology.

Department of Obstetrics and Gynecology, University of Minnesota 26th-

27th September 1991.

20. Carter JR. Cancer of the uterine corpus. Presentation University of

Minnesota Medical School, Department of Obstetrics and Gynecology,

Division of Medical Education Resident Lecture Series 16th November

1991.

21. Carter JR. Transvaginal ultrasound for the gynecologist. Invited speaker


College of Medicine. Current trends in transvaginal ultrasound, including ovarian cancer screening, sponsored by ADR Ultrasound. Cincinnati, Ohio

22nd September 1991.

22. Carter JR. Current trends in transvaginal ultrasound, including ovarian cancer screening. Invited speaker Department of Obstetrics and

Gynecology, University of Cincinnati College of Medicine, sponsored by

ADR Ultrasound. Cincinnati, Ohio 22nd September 1991.

23. Carter JR. Ovarian cancer screening. Presentation Current Concepts in

Ovarian Cancer Conference of the Women's Cancer Center and the

Department of Obstetrics and Gynecology, University of Minnesota 5th

May 1992.

24. Carter JR. Percutaneous urinary diversion in gynecologic oncology.

Presentation University of Minnesota Medical School Department of

Obstetrics and Gynecology Resident Graduation Day 1992:12th June.

25. Carter JR. Pelvic exenteration and continent urinary diversion.

Presentation Ward 7C University Minnesota Hospital and Clinic 24th June

1992.

26. Carter JR. Ovarian cancer in young women. Presentation 23rd Annual

Autumn Seminar: Obstetrics and Gynecology & A Symposium on

Women's Cancer. Department of Obstetrics and Gynecology, University of

Minnesota 22nd-23rd October 1992.

27. Carter JR. Ovarian cancer: catching a killer. Interview by Gordon Slovut

(journalist). Appeared in the Star Tribune newspaper, Minneapolis, MN

1993:10th January.

28. Carter JR. Transvaginal sonography for the gynecologist. Presentation

Grand Rounds University of Minnesota Medical School, Department of


29. Carter JR. Gestational trophoblastic disease. Presentation Abbott North

Western Hospital Tumor Conference Minneapolis MN 1993:12th

February.

30. Carter JR. Vulvar cancer in young women. Presentation 10th Annual

Symposium on Gynecology and Gynecologic Oncology, University of

Minnesota 11th May 1993.

31. Carter JR. Physics and introduction to transvaginal ultrasonography.

Presentation University of Minnesota Medical School, Department of

Obstetrics and Gynecology, Division of Medical Education Resident

Lecture Series 28th May 1993.

32. Carter JR. What's new in transvaginal color flow Doppler. Presentation

"New Horizons in Minnesota Medicine" for the Medical Alumni Society 5th

June 1993.


33. Carter JR. Prediction of malignancy using transvaginal color flow Doppler.

Presentation University of Minnesota Department of Obstetrics and

Gynecology Resident Graduation Scientific Day 18th June 1993.

34. Carter JR. Cancer screening for women. Presentation Har Mar Chalk

Talk, organized by Community Services UMHC 1st July 1993.

35. Carter JR. Life Enhancement. Presentation Hagman Conference Room

University of Minnesota 20th July 1993.

36. Carter JR. An Update on Cervical Cancer. Presentation Fall Meeting of the Southern Chapter of the Minnesota Academy of Family Physicians.

New Ulm, Minnesota 14th September 1993.

37. Carter JR. An Overview of Transvaginal Ultrasound. Presentation Fall

Meeting of the Southern Chapter of the Minnesota Academy of Family

Physicians. New Ulm, Minnesota 14th September 1993.

38. Carter JR. An update on ovarian cancer screening. Presentation 24th

Annual Autumn Seminar: Obstetrics and Gynecology. Presentation and book of abstracts, p131. Department of Obstetrics and Gynecology,

University of Minnesota 21st-22nd October 1993.



40. Carter JR. Ovarian cancer screening.,. Grand Rounds presentation


41. Carter JR. Transvaginal sonography for the gynecologist. Presentation

Grand Rounds University of Minnesota Medical School, Department of

Obstetrics and Gynecology 25th February 1995.

42. Carter JR. Student Problem Based Learning Series. Presentation

University of Minnesota Medical School, Department of Obstetrics and

Gynecology, Division of Medical Education Medical April -June 1995.

43. Carter JR. Color Doppler sonography in gynecologic oncology. Invited speaker 19th Annual Sonography Symposium Vanderbilt University

School of Medicine, Nashville, Tennessee 25th May 1995.

44. Carter JR. Treatment of gynecologic malignancy and the role of the pathologist. Presentation Grand Rounds University of Minnesota Medical

School, Department of Laboratory Medicine and Pathology, Division of

Surgical Pathology 11th October 1995.

45. Carter JR. An update on gynaecologic oncology. Presentation Grand

Rounds Woden Valley Hospital, Canberra, ACT 5th February 1996.

46. Carter JR. Cervical dysplasia. Presentation University of Sydney,

Department of Obstetrics and Gynaecology 22nd February 1996.

47. Carter JR. Update on colour flow Doppler imaging in gynaecology.

Presentation Obstetric and Gynaecology Ultrasound Group. RACOG

College House, Surry Hills 29th February 1996.

48. Carter JR. Ovarian cancer early detection. Presentation Wollongong

Hospital March 27th 1996.

49. Carter JR. Transvaginal sonography in gynaecological oncology.

Presentation Pittwater Radiology Society Meeting Balmoral Sydney 13th

May 1996.

50. Carter JR. Treatment of Cervical Cancer. Presentationi and round table discussion on HPV and cervical cancer, Dept. Microbiology, University of

Sydney 15th July 1996.


51. Carter JR. Laparoscopic surgery in gynaecologic oncology. Presentation

Department of Obstetrics and Gynaecology, Royal Darwin Hospital,

Darwin 11th-13th August 1996.

52. Carter JR. Transvaginal ultrasound for the Gynaecologist. Presentation

Department of Obstetrics and Gynaecology, Fairfield Hospital 19th August

1996.

53. Carter JR. Update Ovarian Cancer. Presentation Department of

Obstetrics and Gynaecology, Registrar Lecture Series, Liverpool Hospital

2nd September 1996.

54. Carter JR. Ovarian cancer: interplay of epidemiologic and genetic factors in development. Presentation Royal Prince Alfred Medical Officers

Reunion Week Scientific Symposium 4th September 1996.

55. Carter JR. Update in the management of common gynaecological cancers. Presentation Update in Gynaecology Symposium. The

Postgraduate Committee in Medicine at The University of Sydney 26th

October 1996.

56. Carter JR. Evaluation of the adnexal mass: implications for laparoscopic surgery. Presentation Sydney Gynaecological Endoscopy Group

Symposium at Liverpool Hospital, Sydney 4th November 1996.

57. Carter JR. Update on Gynaecological Cancers. Presentation 66th

General Revision Course, Postgraduate Committee in Medicine, The

University of Sydney 15th July, 1996.

58. Carter JR. Colour Flow Doppler in Gynaecologic Oncology. Presented at the 3rd National Conference of The Australian Sonographers Association.

Sydney 20-21 July 1996.

59. Carter JR. Laparoscopic pelvic lymphadenectomy. Presented at the Post-

Valedictory Symposium Workshop on Advanced Gynaecological

Laparoscopy, Hysteroscopy & Falloposcopy. National University of

Singapore. 18th-21st November 1996.

60. Carter JR. Transvaginal sonography for the gynaecologist. Presentation

Department of Obstetrics and Gynaecology, Registrar Lecture Series,

Liverpool Hospital 23rd June 1997.

61. Carter JR. Gynaecologic cancer screening" at the Update in Gynaecology

Symposium. Presentation The Postgraduate Committee in Medicine at

The University of Sydney 16th August 1997.

62. Carter JR. Non-epithelial ovarian tumours. Presentation Department of

Obstetrics and Gynaecology, Registrar Lecture Series, Liverpool Hospital

29th September 1997.

63. Carter JR. Evaluation of the adnexal mass: implications for laparoscopic surgery. Presentation University of New South Wales Department of

Obstetrics and Gynaecology and St. Luke's Hospital Complex: A collaborative Practical Gynaecological Endoscopy Workshop. Sydney

Australia 18th-19th October 1997.

64. Carter JR. Evaluation of the adnexal mass: implications for laparoscopic surgery. Presentation Sydney Gynaecological Endoscopy Group

Symposium at King George V Hospital, Sydney 31st October 1997.

65. Carter JR. Ovarian cancer surveillance. Presentation Department of

Obstetrics and Gynaecology, Postgraduate Training Programme. John

Hunter Hospital, Newcastle. 2nd July 1997.


66. Carter JR. Ovarian cancer screening versus early detection. An update.

Presented as The Turnbull Scholar, The University of Melbourne and The

Royal Women's Hospital, Victoria 19th-23rd May 1997.

67. Carter JR. Transvaginal sonography for the gynaecologist. Presented as

The Turnbull Scholar, The University of Melbourne and The Royal

Women's Hospital, Victoria. 19th-23rd May 1997.

68. Carter JR. An update on gynaecologic oncology. Presented as The

Turnbull Scholar, The University of Melbourne and The Royal Women's

Hospital, Victoria. 19th-23rd May 1997.

69. Carter JR. Evaluation of the adnexal mass: implications for laparoscopic surgery. Invited speaker VII Annual Scientific Meeting, Australian

Gynaecological Endoscopy Society Meeting. Sydney Australia. 31st July-

2nd August 1997.

70. Carter JR. Colour flow Doppler in gynaecologic tumour detection.

Presentation Department of Perinatal Medicine, King George V Hospital,

Sydney 8th May 1998.

71. Carter JR. Gynaecological cancer screening update. Presentation The

Liverpool Division of General Practice Women's Health Workshop at

Bigge Street Private Hospital, Liverpool 21st July 1998.

72. Carter JR. Surgery in the retroperitoneal space. Presentation Pelvic

Surgery:Advances and Controversies, Postgraduate Committee in

Medicine, The University of Sydney & Pelvic Surgery Unit, King George V

Hospital. Menzies Hotel, Sydney Australia 17th-18th October 1998.

73. Carter JR. Medicolegal Hypotheticals. Participation Pelvic Surgery:

Advances and Controversies, convened by the Postgraduate Committee in Medicine, The University of Sydney & Pelvic Surgery Unit, King George

V Hospital. Menzies Hotel, , Sydney Australia 17-18th October 1998.

74. Carter JR. Ovarian cancer screening-the gynaecologic oncologists perspective. Invited speaker Annual Scientific Meeting, Australian

Association of Obstetric and Gynaecologic Ultrasonographers Meeting,

Queenstown, New Zealand 20th-23rd August 1998.

75. Carter JR. What is the appropriate clinical approach to screening for cervical cancer? Does ultrasound have a role? Invited speaker Annual

Scientific Meeting, Australian Association of Obstetric and Gynaecologic

Ultrasonographers Meeting, Queenstown, New Zealand. 20-23rd August

1998.

76. Carter JR. The clinicians approach to the diagnosis of uterine neoplasia.

Is ultrasound reliable? Invited speaker Annual Scientific Meeting,

Australian Association of Obstetric and Gynaecologic Ultrasonographers

Meeting, Queenstown, New Zealand 20th-23rd August 1998.

77. Carter JR. Laparoscopy in gynaecologic oncology: we can but should we?

Presentation 9th Annual Scientific Meeting of the Newcastle Obstetrical and Gynaecological Society. John Hunter Hospital 18th September 1998.

78. Carter JR. Pelvic Surgery: Advances and Controversies. Program Chair

Postgraduate Committee in Medicine, The University of Sydney & Pelvic

Surgery Unit, King George V Hospital. Menzies Hotel, Sydney Australia


79. Carter JR. Gynaecologic Oncology Group Meeting. Program Chair

Clinical Oncology Society of Australia (COSA) 25th Annual Scientific

Meeting, Sydney Australia 26th November 1998.


80. Carter JR. Transvaginal Ultrasound by a Clinician for Clinicians.

Presentation King George Vth Hospital Fetal Medicine and Ultrasound

Department weekly meeting 10th September 1999.

81. Carter JR. The role of preradiation surgical staging for cervical cancer.

Presentation The Gynaecological Oncology Study Group Meeting. Royal

Hospital For Women, Randwick, NSW 5th November 1999.

82. Carter JR. Transvaginal ultrasound of uterus and cervix. Presentation

King George Vth Hospital Fetal Medicine and Ultrasound Department weekly meeting 12th November 1999.

83. Carter JR. Conventional approaches to hysterectomy. Presentation

Alternatives to Hysterectomy Public Lecture Series. Sir John Clancy

Auditorium, University of New South Wales 13th November 1999.

84. Carter JR. Conventional approaches to hysterectomy. Presentation

Alternatives to Hysterectomy Workshop. University of New South Wales.

Novotel Hotel, Brighton, NSW 14th November 1999.

85. Carter JR. Ovarian Cancer. Program Chair Update on Gynaecological

Oncology, Session 4, Royal Hospital for Women, Randwick 30th April-1st

May 1999.

86. Carter JR. An experience with transvaginal sonography in gynaecological tumour detection. Invited speaker University of Minnesota Division of

Gynecologic Oncology Consensus Conference. Minneapolis Minnesota

16th October 1999.

87. Carter JR. Overview of corpus cancer. Presentation RANZCOG Registrar

Training Series. Scott Skirving Lecture Theatre, Royal Prince Alfred

Hospital 18th February 2000.

88. Carter JR. Management of abnormal Pap smears: when to wait and when to refer, use of HPV testing; does endocervical material matter; current management techniques. Presentation Women's Health Update.

Postgraduate Committee in Medicine. The University of Sydney 1st April

2000.

89. Carter JR. Approaches to the management of corpus cancer.

Presentation Advances and Controversies in Gynaecology and Pelvic

Surgery II. The University of Sydney 7th-8th October 2000.


Presentation MRANZCOG Pre-Exam Course. Northern Sydney Education


91. Carter JR. Women's Health Update for General Practitioners. Program

Chair Postgraduate Committee in Medicine, The University of Sydney 5th

August 2000.

92. Carter JR. Evaluation of Pelvic Mass. Invited speaker Western

Metropolitan Obstetric & Gynaecological Society Liverpool Hospital 20th

August 2000.

93. Carter JR. The Pap test and cervical screening: an update. Presentation

South East NSW Division of General Practice Ltd Women's Health

Seminar. Rydges Lakeside, London Circuit Canberra 10-11th March 2001.

94. Carter JR. Update on Gestational Trophoblastic Disease. Presentation

Liverpool Hospital Department Obstetrics & Gynaecology 27th July 2001.

95. Carter JR. Evaluation of the adnexal mass: implications for laparoscopic surgery. Presentation Fairfield Hospital Department of Obstetrics and

Gynaecology 12th November 2001.


96. Carter JR. Gynaecology for General Surgeons. Chairman General

Surgical Training Course Programme Johnson & Johnson Education

Institute, Ryde NSW 4th July 2001.



Centre, Macquarie Hospital, North Ryde 26th-30th November 2001.

98. Carter JR. Ovarian cancer treatment in Australia. Invited speaker The

University of Minnesota Women's Cancer Centre. Minneapolis, MN 4th

March 2001.

99. Carter JR. Endometrial cancer: current management. Presentation

RANZCOG NSW State Committee Registrar Training Symposia. Royal

Prince Alfred Hospital 21st June 2002.




101. Carter JR. Overview of Gynaecological Cancers. Presentation The New

South Wales College of Nursing 12th August 2002.

102. Carter JR. Overview of Gynaecological Cancers. Presentation The New

South Wales College of Nursing 14th October 2002.

103. Carter JR. Gynaecology for General Surgeons. Chairman General

Surgical Training Course Programme Johnson & Johnson Education

Institute, Ryde NSW 19th June 2002.

104. Carter JR. Laparoscopy in gynaecological oncology, we can but should we. Invited speaker 1st Guangzhou International Symposium on

Oncology. Guangzhou China 28th-30th April 2002.

105. Carter JR. How to follow up treated patients. Invited speaker Meet the

Professor Series. 9th Biennial Meeting of the International Gynecologic

Cancer Society. Seoul, Korea. 20th-24th October 2002.

106. Carter JR. Surgical management of gynaecological cancer. Presentation

Medical Oncology Advanced Trainees Weekend, Shangri La Hotel,

Sydney 2nd November 2003.


Presentation MRANZCOG Pre-Exam Course. Twin Towers Inn, Artarmon.

24th November 2003.

108. Carter JR. Advances in surgery in gynaecological oncology. Presentation

Gynaecological Oncology CNC Network Study Day. Royal Hospital for

Women 12th March 2004.

109. Carter JR. Cervical Cancer Screening into the 21st Century. Presentation

Ristorante Ecco, 2 St George Cres, Drummoyne sponsored by Cytyc 6th

May 2004.

110. Carter JR. Cervical cancer screening: into the 21st century or are we stuck in the past. Presentation Sydney Cancer Centre Grand Rounds, The

Sydney Cancer Centre. Royal Prince Alfred Hospital. 26th July 2004.

111. Carter JR. Surgical Management of Gynaecological Cancer. Presentation

Medical and Radiation Oncology Registrar's Training Day Mayne Pharma,

Shangri La Hotel, The Rocks, Sydney 18th September 2004.


Presentation MRANZCOG Pre-Exam Course. Mercure Hotel, St Leonards

8th November 2004.


113. Carter JR. Cervical Cancer Screening into the 21st Century. Presentation

Advances in Gynaecologic Oncology. Sydney Cancer Centre Royal Prince

Alfred Hospital 10th November 2004.

114. Carter JR. External Examiner (Conjoint appointment with Universiti of

Malaya, Universiti Sains Malaysia and University Kebangsaan Malaysia.

Master of Obstetrics and Gynaecology Examinations (Part II) Kuala

Lumpur, Malaysia 16th-19th May 2004.



26th July 2004.

116. Carter JR. Advances in Gynaecologic Oncology. Program Chair Sydney

Cancer Centre and the Sydney Gynaecologic Oncology Group 10th

November 2004.

117. Carter JR. Gynaecological cancer-screening and diagnosis. Presentation.

RANZCOG Update Course in Office Gynaecology. Northern Sydney

Education Centre, Macquarie Hospital, North Ryde. 18 th January 2005

118. Carter JR.

Presented “Postoperative Care”. Ward 7E2 In Service Lecture.

28 th January 2005

119. Carter JR.

Cancer and You. Presentation to staff at Allianz 2006;5th April

2006.

120. Carter JR.

Gynaecological cancer: incidence and mortality. Approaching the care of patients with advanced or recurrent gynaecological cancer

2006;Sydney Institute of Palliative Medicine(7th-8th April).

121. Carter JR.

HPV in sexually active women-vaccinate or smear? Sydney

Annual Hormone & Women’s Health Update & Education Day. Clancy

Auditorium, UNSW Kensington. Saturday 21 February 2009.

122. Carter JR.

Ovarian and other pelvic cancers-update and overview.

Sydney Annual Hormone & Women’s Health Update & Education Day.

Clancy Auditorium, UNSW Kensington. Saturday 21 February 2009.


Fast track surgery in gynaecological oncology. A clinical audit.

Presentation at RPAH Heads of Department Bi-Monthly Meeting. John

Greenaway Room 28 th April 2009.

124. Carter JR.

Presentation on “Fast Track Surgery” at 6 th Annual Advances in Gynaecological Oncology. A Tribute to Malcolm Coppleson. Kerry

Packer Auditorium Royal Prince Alfred Hospital. 20 th November 2009.

125. Carter JR.

Presentation at RPAH Surgical Patient Flow Committee

Meeting. Fast Track Surgery in Gynaecological Oncology. 2 nd July 2010

126. Carter J.

Presentation at 7 th Annual Advances in Gynaecological

Oncology. Kerry Packer Auditorium Royal Prince Alfred Hospital. 5 th

November 2010.

127. Carter J.

Presentation at RPAH JL Theatres Nurses Meeting. Fast track surgery in uterine corpus cancer. 7 th December 2010

128. Carter J.

Presentation An overview of diagnosis and management of ovarian cancer at 8 th Annual Advances in Gynaecological Oncology. Kerry

Packer Auditorium Royal Prince Alfred Hospital. 28 th October 2011.

129. Carter J.

Invited speaker Inner West Sydney Medicare Local

Gynaecology Symposium. Cervical disease, HPV and management of the abnormal pap smear. 12 th June 2013


Attendance at Courses/Conferences

1. Carter J . Chair and presented at 8 th Annual Advances in Gynaecological

Oncology. Kerry Packer Auditorium Royal Prince Alfred Hospital. 28 th October

2011

2. Carter J . Invited speaker Inner West Sydney Medicare Local Gynaecology

Symposium. Cervical disease, HPV and management of the abnormal pap smear. 12 th June 2013

3.

Carter J . Attended RANZCOG SIMG Training Supervisor Workshop. St

Leonards NSW. 23 rd August 2013. (7 CPD Points in Meetings Category)

4.

Carter J . Attended 23 rd World Congress on Ultrasound in Obstetrics and

Gynaecology. 6-9 th October 2013 (8 CPD Points)

5.

Carter J . Attended and speaker 2013 NSW Health Innovation Symposium

11 th October 2013

6. Carter J.

Attended and Invited Speaker. Postgraduate Seminar Hong Kong

College of Obstetricians & Gynaecologists. Optimising Recovery After

Surgery. Hong Kong. 9 th March 2014

7. Carter J.

Attended and Invited Speaker. Postgraduate Seminar Hong Kong

College of Obstetricians & Gynaecologists. An Overview of Apparent Early


8. Carter J.

Attended and Invited Speaker. University of Hong Kong.

Department of Obstetrics and Gynaecology. An Overview of Apparent Early


9. Carter J.

Attended. ANZGOG/ASGO Combined Annual Scientific Meeting.

Hyatt Hotel Canberra. 26-29 th March 2014. Approved 26 CPD Points

jonathan robert carter - The University of Sydney

OJOG

he Australian Gynaecological Cancer

Foundation. 24

February 2014.

Related documents

Products

Support

jonathan robert carter - The University of Sydney

OJOG

he Australian Gynaecological Cancer

Foundation. 24

February 2014.

Related documents

Add this document to collection(s)

Add this document to saved

Suggest us how to improve StudyLib